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FORUM REVIEW ARTICLE
Redox-Modulated Phenomena and Radiation Therapy:
The Central Role of Superoxide Dismutases
Aaron K. Holley,1 Lu Miao,1 Daret K. St. Clair,1 and William H. St. Clair2
Abstract
Significance: Ionizing radiation is a vital component in the oncologist’s arsenal for the treatment of cancer.
Approximately 50% of all cancer patients will receive some form of radiation therapy as part of their treatment
regimen. DNA is considered the major cellular target of ionizing radiation and can be damaged directly by
radiation or indirectly through reactive oxygen species (ROS) formed from the radiolysis of water, enzyme-
mediated ROS production, and ROS resulting from altered aerobic metabolism. Recent Advances: ROS are
produced as a byproduct of oxygen metabolism, and superoxide dismutases (SODs) are the chief scavengers.
ROS contribute to the radioresponsiveness of normal and tumor tissues, and SODs modulate the radio-
responsiveness of tissues, thus affecting the efficacy of radiotherapy. Critical Issues: Despite its prevalent use,
radiation therapy suffers from certain limitations that diminish its effectiveness, including tumor hypoxia and
normal tissue damage. Oxygen is important for the stabilization of radiation-induced DNA damage, and tumor
hypoxia dramatically decreases radiation efficacy. Therefore, auxiliary therapies are needed to increase the
effectiveness of radiation therapy against tumor tissues while minimizing normal tissue injury. Future Direc-
tions: Because of the importance of ROS in the response of normal and cancer tissues to ionizing radiation,
methods that differentially modulate the ROS scavenging ability of cells may prove to be an important method
to increase the radiation response in cancer tissues and simultaneously mitigate the damaging effects of ionizing
radiation on normal tissues. Altering the expression or activity of SODs may prove valuable in maximizing the
overall effectiveness of ionizing radiation. Antioxid. Redox Signal. 20, 1567–1589.
Introduction
The International Agency for Research on Cancerhas estimated an annual diagnosis of 12.7 million new
cases of cancer and 7.6 million cancer-related deaths world-
wide (105). Radiation therapy is used alone, or in conjunction
with, chemotherapy, immunotherapy, surgery, and hormone
therapy for the treatment of cancer (10). In fact, *50% of all
cancer patients will receive some form of radiation as an im-
portant element in their treatment regimen (43).
The medical application of ionizing radiation was realized
early after the discovery of X-rays by Röntgen in 1895, when
Emil Grubbé used X-rays to treat an ulcerated breast cancer
60 days after the discovery of X-rays (15). Since that time,
efforts have been made to improve the efficacy of radiation
therapy, increasing the killing effect on cancer cells while
minimizing the detrimental effects on normal tissues. Var-
ious drugs have been developed to modulate the DNA
damage response in tumor cells, alter the activation of signal
transduction pathways activated after irradiation, and con-
trol the influence of the tumor microenvironment [reviewed
in ref. (12)]. Despite these advances, there is a need for fur-
ther improvements.
Reactive oxygen species (ROS) are produced as a by-
product of oxygen metabolism (70). ROS, while harmful to
cells when produced in excess through oxidative modification
of lipids, proteins, and DNA, are also vital mediators of
multiple cellular processes, including cell growth and differ-
entiation (18), the immune response, cell adhesion, and apo-
ptosis (47). ROS are also second messengers in cell signaling
(69, 81, 181, 210). The rate of ROS production and destruction
is carefully maintained in the cell, and interruption of this
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process contributes to the development of different diseases,
including cancer (75, 210, 215).
ROS play a major role in the damaging effects of low linear
energy transfer (LET) ionizing radiation on cancer cells. ROS
are formed by the radiolysis of water, and these ROS (137),
particularly the hydroxyl radical (214), participate in dam-
aging DNA. Roughly two-thirds of radiation-mediated
DNA damage is caused by indirect effects from ROS (146).
Although radiation is an important treatment for cancer, it can
also be harmful to normal tissues (1). Therefore, methods that
can simultaneously increase the radiosentivity of cancer cells
and radioresistance of normal tissues are needed to improve
the treatment outcome in patients.
Mitochondria are the major sites of metabolic ROS pro-
duction in the cell, with the superoxide radical as the primary
ROS generated by the organelle as a byproduct of oxidative
phosphorylation (2, 97). Cells are equipped with many sys-
tems to scavenge ROS, with the superoxide dismutases
(SODs) as the chief ROS scavenging enzymes in the cell (228).
Because of the importance of ROS in cancer development, and
the role of ROS in the radiation-induced damage, methods to
alter the redox environment of cancer cells may enhance the
response of cancer cells to ionizing radiation.
In this review, we will discuss the effects of ionizing radia-
tion on the cell. We will also discuss two factors that affect the
efficacy of radiation therapy: the bystander effect and the tu-
mor microenvironment. We will also discuss SODs, their role in
cancer development, and their importance in the radiation re-
sponse of both normal tissues and cancer cells. Finally, we will
detail different methods to increase SOD expression and/or
activity and its effects on simultaneously protecting normal
tissues and sensitizing tumor tissues to ionizing radiation.
Effects of Radiation on Biological Tissue
The primary target of ionizing radiation in the cell is
chromosomal DNA. Ionizing radiation damages intracellular
molecules by direct ionization and through indirect ioniza-
tions mediated by water radiolysis products (Fig. 1A), with an
estimated two-thirds of radiation-induced DNA damage due
to indirect effects (146). This process elicits myriad types of
DNA damage, including base and sugar damage, as well as
single- and double-strand breaks. Radiolysis of water leads to
the formation of a variety of free radicals. For example, water
is ionized to form a radical and a free electron. The water
radical can either undergo decomposition or interact with a
water molecule to form hydroxyl radicals. The free electron
can be hydrated by surrounding water molecules, and this
stabilized electron can interact with another water molecule
to form a hydroxyl radical or a proton to form a hydrogen
radical (137) (Fig. 1B). Direct effects of ionizing radiation on
DNA lead to a variety of damage products, such as oxidized
bases and cleavage of the sugar–phosphate backbone (Fig. 2)
(189). Water radiolysis products can damage nucleic acids
(Fig. 3) and other cellular molecules, including proteins and
lipids (180, 214). Free radical damage of DNA, whether direct
or indirect, results in the formation of myriad types of DNA
lesions (137, 167, 182). Base lesions may be benign, with no
apparent effect on the cell after irradiation, or the base lesions
may lead to miscoding of the DNA, resulting in mutation
formation. Single-strand breaks can also form, which may
result in mutation formation if this damage is not properly
repaired. Double-strand breaks also occur, in particular,
following the replication of DNA that sustained oxidative
damage, resulting in chromosomal abnormalities (137). These
double-strand breaks, if not re-annealed at the site of the
original break, may re-anneal with other breaks on the same
chromosome or a different chromosome to form chromo-
somal aberrations (88). Chromosomal aberrations are divided
into two broad types: chromosome type and chromatid type.
Chromosome-type aberrations occur when breaks and re-
joining change both sister chromatids at one locus (Fig. 4A).
Chromatid-type aberrations occur when breaks and rejoinings
alter only one sister chromatid at any one locus (Fig. 4B).
The type of damage that occurs after irradiation depends
on the stage of the cell cycle at which a cell is irradiated.
Chromosome-type aberrations typically occur during G1 of
the cell cycle, whereas chromatid-type aberrations typically
occur during G2 and S phases of the cell cycle (3).
Another important type of radiation-induced DNA damage
identified is referred to as clustered damage, where two or more
closely spaced types of damage occur, such as abasic sites, ox-
idized bases, and tandem lesions, contributing to the formation
of double-strand breaks (77, 78, 198, 213) (Fig. 5). This clustered
damage is thought to have significant biological consequences
because it is much more difficult to repair. Clustered damage is
longer-lived, increasing the likelihood of incorporation of an
inappropriate base, resulting in mutation formation [reviewed
in ref. (152)]. Unrepaired clustered damage also leads to a
multitude of chromosomal aberrations (5), and attempts to re-
pair clustered damage can result in further double-strand break
formation (191). Not only does clustered damage form from the
direct interaction of ionizing radiation with DNA, it can also be
induced by ROS, including hydroxyl radicals (180).
Although radiation therapy has proven valuable in the
treatment of cancer, it can also have detrimental side effects.
Tissues most susceptible to ionizing radiation are those with a
high replication rate and are least differentiated (1). This
characteristic makes cancer cells, with their high proliferation
rate, more prone to radiation-induced damage than normal
tissues (12), but can also affect normal tissues (1). One example
of the detrimental effects of ionizing radiation is the formation
of secondary cancers. Diallo et al. studied the frequency of
secondary cancer formation in relation to irradiated volume in
patients with childhood cancer that received radiation therapy.
The researchers found that the majority of secondary tumors
(66%) formed in the region bordering planning target volume,
and a small percentage of tumors formed in a region > 5 cm
from the irradiated volume (22%) or within the irradiated
volume (12%) (46). Therefore, methods that increase the
radiosensitivity of cancer tissues and simultaneously increase
the radioresistance of normal tissue are needed.
Radiation-Induced Bystander Effect
Description
The bystander effect is defined as an induction of some
biological effect in cells that have not been directly traversed
by radiation but are in close proximity to a cell that has re-
ceived radiation (87). Radiation-mediated changes in unirra-
diated cells can be divided into three classifications: bystander
effects, abscopal effects, and cohort effects. Bystander ef-
fects occur in cells in an irradiated tissue that are not di-
rectly bombarded by radiation. Abscopal effects occur to
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unirradiated cells outside the irradiated volume. The cohort
effect is an indirect effect within an irradiated cell due to some
signal received by another irradiated cell within the same ir-
radiated tissue (17) (Fig. 6). Several biological endpoints have
been used to prove the presence of radiation-induced by-
stander effect, including micronuclei formation, clonogenic
survival, mutation formation, apoptosis, and neoplastic
transformation, among others [reviewed in refs. (34) and (89)].
Another important consequence of the bystander effect is in-
creased radioresistance in nonirradiated tissue. For example,
the exposure of normal human lung fibroblasts (NHLFs) to
medium from HLFs irradiated with 1 cGy c-rays increased
clonogenic survival after exposure to 10 and 19 cGy radiation.
The increased radioresistance in bystander cells correlated
with an increase in the expression of AP-endonuclease (102).
One of the first reports of a radiation-induced bystander
effect was a study by Nagasawa and Little (145), in which
the researchers reported the induction of sister chromatid
exchanges in Chinese hamster ovary (CHO) cell cultures ex-
posed to very low mean doses of a-particles (0.31 mGy). While
less than 1% of the cell nuclei were struck by an a-particle, 30%
of the cells had increased sister chromatid exchange. Irradia-
tion with X-rays (65, 112, 226) and low LET b-particles (163)
also produced stressful bystander effects.
Irradiated cells can induce a bystander effect long after the
irradiation event. Lyng et al. (129) found that medium col-
lected from progeny cells of c-irradiated HPV-G human ker-
atinocytes up to passage 7 after irradiation induced rapid
calcium fluxes, loss of mitochondrial membrane potential,
and increased ROS production in bystander HPV-G cells. No
differences were observed in the bystander effect between
medium collected from irradiated cells or from the cells pas-
saged from the irradiated cells (129). A better understanding
of the mechanisms of the bystander effect can lead to im-
provements in cancer therapy that mitigate harmful effects
of radiation on nontarget tissue.
FIG. 1. Effects of ionizing radia-
tion on DNA. (A) DNA can either
be damaged directly by ionizing
radiation to form a base radical, or
DNA can be damaged indirectly
through radiation-induced ioniza-
tion of water to form hydroxyl
radicals, which cause base radical
formation. (B) Interaction of ioniz-
ing radiation with water either
leads to an excited form of water or
ionization of water to form a water
radical and a free electron. Hydrox-
yl radical formation occurs by
various mechanisms through the
interaction of the free electron with
water or decomposition of the wa-
ter radical.
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FIG. 2. Direct damage to DNA by ionizing radiation. (A) Oxidation of guanine (Gua) to 8-oxoGua. (B) Radiation induced
cleavage of cytosine (Cyt) from the sugar–phosphate backbone. Modified from Shibata et al. (190).
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Mechanisms of the bystander effect
Direct intercellular communication by junctional channels.
Microbeam technology has proven invaluable for study of
the bystander effect, allowing for the delivery of a specific
dose of radiation to an individual cell or groups of cells,
leaving surrounding cells untouched [reviewed in ref. (170)].
Alpha particle irradiation of 20% of AL human hamster hybrid
cells in a microbeam dish resulted in a threefold higher mu-
tation fraction than predicted due to the formation of mu-
tations in nonirradiated cells. When cells were pretreated
with the gap junction intercellular communication (GJIC)
inhibitor lindane, there was a significant reduction in mu-
tation formation, indicating the importance of cell–cell
communication in the induction of the bystander effect (231).
Further studies revealed that GJIC is vital for propagating
signals involved in the bystander effect. Inhibition of gap
junction communication by chemical inhibitors or by ex-
pression of a dominant-negative form of connexin-43 (Cx43)
resulted in diminution of bystander effect-induced mutation
frequency (162, 233). Using various fibroblast and epithelial
cell lines, Azzam et al. (8) demonstrated the importance of
GJIC in the bystander effect. The researchers found that
treatment of the cells with a-particles resulted in the induc-
tion of p21Waf1, and pretreatment with the GJIC inhibitor
lindane, use of cells that are GJIC incompetent or use of Cx43
knockout cells, resulted in diminished radiation-induced
p21Waf1 levels (8).
GJIC is also important in potentiating the cell-killing effects
of ionizing radiation due to the propagation of stress signals
throughout the irradiated volume. Little effect is seen with
low LET radiation, but a significant enhancement is observed
for high LET radiation. Using confluent cultures of AG1522
human diploid fibroblasts, Autsavapromporn et al. (6) dis-
covered that incubation of the cells for 3 h after irradiation
with a-particles resulted in decreased survival and increased
DNA damage compared to cells irradiated with c-rays. This
effect was due to GJIC and was attenuated by pretreatment
with the GJIC inhibitor AGA or knockdown of Cx43 by siR-
NA (7). A similar enhancement of cell killing and DNA
damage was observed for high-charge high-energy iron ions
compared to protons (6).
Intercellular communication via release of soluble fac-
tors. Numerous studies have found that conditioned me-
dium obtained from irradiated cells induces a bystander effect
in unirradiated cells, suggesting soluble factors released by
irradiated cells are involved in the bystander effect. For ex-
ample, Mothersill and Seymour (141) found that treatment of
various epithelial cell lines with the medium from c-ray-
treated cells led to a decrease in clonogenic survival in both a
radiation dose- and irradiated cell number-dependent man-
ner. This effect was only seen in the medium from irradiated
cells, and not irradiated medium in the absence of cells (141).
Similar results have been reported in various cell types using
FIG. 3. Hydroxyl radical-induced DNA damage. A DNA base is attacked by a hydroxyl radical to form a base radical. In
the presence of oxygen, this base radical is stabilized by the formation of a peroxide. A base-sugar radical transfer occurs,
placing the free radical on the ribose. Hydrolytic cleavage then occurs, resulting in a strand break. Modified from Rhee et al.
(181) and Waris and Ahsan (215).
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different methods, including medium transfer (123, 159),
double mylar dishes (which allow exchange of medium be-
tween irradiated and nonirradiated cells) (232), and micro-
beam treatment (14, 169), leading to increased apoptosis
(14, 123, 159, 169), ROS formation (159), as well as micronuclei
formation (14, 169).
Extracellular DNA (ecDNA) has recently been identified
as an important soluble factor that stimulates the bystander
effect. Ermakov et al. (60) discovered that release of ecDNA
from X-ray-treated primary human lymphocytes induced a
bystander effect in nonirradiated lymphocytes. Both the re-
lease of ecDNA and induction of the bystander effect were
blocked by the administration of the antioxidant a-tocopherol.
Based on these results, the researchers suggested that ROS are
important for both the response to radiation, leading to apo-
ptosis and release of ecDNA, and induction of DNA damage
in bystander cells (60). Similar results have been observed in
X-ray-treated human umbilical vein endothelial cells (HU-
VEC) (61, 118). The authors proposed that ecDNA is released
due to ROS-mediated apoptosis induced by ionizing radia-
tion. DNA-binding receptors (TLR9) on bystander cells detect
these DNA fragments, stimulating ROS production and DNA
damage. Inhibition of TLR9 by treatment with an oligonu-
cleotide inhibitor or chloroquine blocked the bystander effect,
whereas treatment of unirradiated cells with ecDNA isolated
from irradiated cell medium stimulated the bystander effect
FIG. 4. Chromosomal aberrations after ionizing radiation. (A) Chromosome-type aberrations occur when breaks and
rejoinings change both sister chromatids at one locus. (B) Chromatid-type aberrations occur when breaks and rejoinings alter
only one sister chromatid at any one locus. To see this illustration in color, the reader is referred to the web version of this
article at www.liebertpub.com/ars
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(61, 118). These results suggest that scavenging of ROS may be
a valuable strategy for assuaging the bystander effect.
Altered gene expression and signal transduction. Induc-
tion of the bystander effect leads to the activation of various
signal transduction pathways and different transcription
factors, resulting in changes in gene expression, culminating
in the biological endpoints that characterize the bystander
effect. Two important genes identified in the bystander effect
are cyclooxygenase-2 (COX-2) and insulin growth factor
binding protein 3 (IGFBP-3). Zhou et al. (229) using NHLFs
found that a-particle irradiation resulted in a bystander effect
by a reduction in the surviving fraction and an increased
mutagenesis rate. Using a signal transduction gene array, the
researchers identified a significant increase in the expression
of COX-2 gene and a decrease in IGFBP-3 gene expression. Co-
treatment of NHLFs with NS-398 (a COX-2 inhibitor) reduced
the mutagenesis rate in bystander cells, and addition of
IGFBP-3 increased survival and decreased the mutagenesis
rate in bystander cells. Treatment of the cells with either the
MAP kinase inhibitor PD98059 or an anti-tumor necrosis
factor-alpha (TNF-a) antibody significantly blocked the by-
stander effect (229).
Bystander effect in vivo
While a multitude of studies demonstrate an in vitro by-
stander effect, the bystander effect has also been confirmed
FIG. 5. Model of clustered dam-
age of DNA after ionizing radia-
tion. Clustered DNA damage can
occur after direct ionization by ra-
diation or by radiation-induced
ROS formation, leading to the for-
mation of base damage (orange
circles), abasic sites, and tandem
lesions, resulting in single- and
double-strand breaks. ROS, reactive
oxygen species. To see this illustra-
tion in color, the reader is referred
to the web version of this article at
www.liebertpub.com/ars
FIG. 6. The bystander effect.
Three major types of bystander ef-
fects occur in irradiated tissues.
Bystander effects (A) occur in unir-
radiated cells within a low-dose-
irradiated tissue. Abscopal effects
(B) occur to unirradiated cells out-
side the irradiated volume. The co-
hort effect (C) occurs between
irradiated cells within an irradiated
tissue volume. To see this illustra-
tion in color, the reader is referred
to the web version of this article at
www.liebertpub.com/ars
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in vivo in various model systems, such as Caenorhabditis ele-
gans, zebra fish, and Arabidpopsis thaliana [reviewed in ref.
(30)]. Studies of partial lung c-ray treatment in rats revealed
that the lower lung is much more sensitive to the in-field ef-
fects of radiation (as determined by micronuclei formation)
than the upper lung, whereas the upper lung demonstrated
greater response to bystander effects after lower lung irradi-
ation. Copper-zinc superoxide dismutase (CuZnSOD), man-
ganese superoxide dismutase (MnSOD), or the nitric oxide
synthase inhibitor nitro-l-arginine methyl ester dissolved in
saline and administered by intraperitoneal injection, signifi-
cantly reduced both in-field and bystander effects, suggesting
a role for ROS in bystander effects in vivo (114, 115). In-field
and bystander effect induction of inflammatory cytokines
is also involved in the response to partial lung c-ray treat-
ment (28), as well as X-ray treatment of the abdomen (211).
Koturbash et al. found that X-irradiation of the cranium of
mice increased double-strand DNA breaks, p53 expression,
cell proliferation, and apoptosis in the lead-shielded spleen of
the animals (120), and these bystander effects on the spleen
were sex specific, with male bystander spleens demonstrat-
ing significantly greater DNA damage and loss of DNA
methylation compared to bystander female spleens. These
sex-specific differences in bystander effect were diminished in
animals that had undergone surgical removal of their gonads
(119). These results indicate that the bystander effect is a
complex phenomenon in vivo and that strategies designed to
assuage the bystander effect may need to take into account
sex-specific differences.
Bystander effect in neoplastic transformation
Not only can the bystander effect result in cellular damage
and death in nonirradiated cells, it can also induce neoplastic
transformation in nonirradiated cells. Exposure of CGL1 HeLa
skin-fibroblast hybrid cells to medium collected from X-ray-
treated HeLa-skin fibroblast hybrid (CGL1) cells significantly
increased the neoplastic transformation frequency (123). A
similar increase in neoplastic transformation has been observed
in JB6 mouse epithelial cells co-cultured with JB6 cells treated
with c-rays (216). Bystander effect-mediated neoplastic trans-
formation has also been observed in vivo. Mancuso et al., using
Patched-1 (Ptch1) heterozygous knockout mice (Ptch1 + / - ),
discovered that medulloblastoma formation was significantly
greater in Ptch1 + / - mice with their heads shielded (but the
remainder of their body receiving radiation treatment) com-
pared to untreated mice but was not as great as mice receiving
whole-body radiation (134). A later study investigated the role
of GJIC on propagation of bystander effect signaling in vivo and
its role in radiation-associated bystander effect cancer forma-
tion in a Cx43 heterozygous knockout mouse (Cx43 + / - ) model.
Radiation-induced medulloblastoma formation was signifi-
cantly lower in shielded Cx43+ / - /Ptch + / - mice compared to
shielded Cx43 + / + /Ptch+ / - mice, confirming the role for GJIC
in bystander effect-mediated neoplastic transformation (133).
The bystander effect may also contribute to neoplastic
transformation in humans. In a study by Diallo et al. (46) in-
vestigating the formation of secondary cancer formation in
childhood cancer patients who received radiation therapy,
there was a substantially greater number of secondary cancers
that developed at distant sites from the irradiated volume (25
neoplasms) than what was predicted (nine neoplasms). In this
study, the authors defined distant as any area farther than
5 cm outward from the edge of the irradiated volume (46).
Given the effects of the bystander effect on neoplastic trans-
formation discussed above, these results suggest that an im-
portant bystander effect may also be occurring in humans
that may contribute to the secondary cancer formation after
radiation treatment. Therefore, adjuvant therapies that can
mitigate these unwanted effects of radiation therapy would
prove valuable in the clinic.
Although irradiated cells can communicate to unirradiated
cells through the bystander effect, bystander cells can com-
municate back to the irradiated cells. Chen et al. found that
incubation of a-particle-irradiated NHLFs with bystander
NHLFs significantly reduced 53BP1 foci formation (a marker
of double-strand breaks), as well as diminished micronuclei
formation and apoptosis, in the irradiated cells compared to
irradiated cells not incubated with bystander cells (36).
Similar reductions in micronuclei formation have been ob-
served in a-particle-irradiated HeLa incubated with NHLFs
(36) and incubation of X-irradiated Me45 human melanoma
cells with normal human dermal fibroblasts (219), and the
reduction in micronuclei formation corresponded with re-
duced ROS formation in the irradiated cells (219). These re-
ports suggest that the bystander effect and reciprocal
communication from bystander cells back to irradiated cells is
an important component in the complex response of an or-
ganism to ionizing radiation. This type of communication
may have important implications in radiation resistance in
cancer cells and may provide an important target to increase
radiosensitivity in cancer, especially within the context of
therapies that exploit oxidative stress.
ROS in the bystander effect
ROS are important mediators of the bystander effect by
myriad mechanisms. Incubation of bystander cells with the
conditioned medium from c-ray-treated human keratinocytes
in the presence of the antioxidant N-acetylcysteine (NAC) or
the caspase-9 inhibitor Z-LEHD-FMK abrogated the effects of
the conditioned medium on bystander keratinocytes (130).
Increased lipid oxidation after irradiation with c-rays (as
measured by malondialdehyde formation) has also been ob-
served in both irradiated and bystander Me45 cells and cor-
related with a significant decrease in the MnSOD activity
(171). ROS formation was associated with micronuclei for-
mation and c-H2AX foci formation in bystander AG01522
normal human fibroblasts, which was inhibited by the ad-
dition of either CuZnSOD or catalase (final concentration
500 U/ml and 8 · 103 U/ml, respectively) directly into the
culture medium immediately after irradiation (226). Similar
results have been reported in human peripheral blood lym-
phocytes (13). In HaCaT human keratinocytes, viability of
bystander cells was rescued by incubation of either the by-
stander cells or the c-ray-treated cells with SOD or catalase
(added directly to the cell culture medium), suggesting ROS
are both a source of bystander signals and carry out the by-
stander effect in recipient cells (127). ROS also initiate the
bystander effect by stimulating ecDNA release from irradi-
ated cells and response of bystander cells (see discussion
above). Therefore, methods that increase ROS scavenging
ability in cells may simultaneously abrogate both the genera-
tion of bystander signals and the response to bystander signals.
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Mitochondria and the bystander effect
Mitochondria are the primary source of ROS in the cell due
to oxygen metabolism through oxidative phosphorylation
(22, 122, 144), with complexes I (83, 200) and III (205) as major
contributors of superoxide produced by mitochondria. Be-
cause mitochondria produce ROS, and the role of ROS in
propagation of the bystander effect (discussed above), logic
dictates that mitochondria may be important in the bystander
effect. Rajendran et al. (178) used various human lympho-
blastoid cell lines treated with X-rays to study the effects of
mitochondrial DNA (mtDNA) mutations on the bystander
effect. The researchers found that medium from irradiated cell
lines with normal mtDNA stimulated a bystander effect
(micronucleus formation) in the same cell line or other cell
lines with normal mtDNA, but not in cell lines harboring
mtDNA mutations. Medium from irradiated cell lines with
mtDNA mutations was unable to stimulate a bystander effect
in either normal cell lines or cell lines with mtDNA mutations.
These results suggest that functioning mitochondria are vital
for both generation and reception of bystander signals (178).
Mitochondria as sources of the bystander effect. Studies
using AL human-hamster hybrid cells with either normal
mtDNA (q + ) or depleted of mtDNA (q0) have established the
contribution of mitochondria in generation of bystander sig-
nals from irradiated cells. Either depletion of mtDNA or in-
hibition of the electron transport chain, as well as inhibition of
NO production or calcium uptake, significantly reduced c-
H2AX foci, a marker of DNA damage, in bystander cells (37).
A reduction in the bystander effect has also been observed in
AG1522 cells incubated with the medium from a-particle-ir-
radiated q0 AL cells (38). Depletion of mtDNA had similar
results in a-particle-irradiated HeLa cells (202) and human
skin fibroblasts (230).
Mitochondria as targets of the bystander effect. Not only
are mitochondria important initiators of the bystander effect,
they are also recipients of bystander signals. For example,
treatment of human keratinocytes with the medium from
keratinocytes treated with c-rays resulted in rapid calcium
flux, increased ROS production, and decreased mitochondrial
membrane potential, as well as increased apoptosis and de-
creased clonogenic survival (128). Direct irradiation of Chi-
nese hamster ovary K1 cells or HPV-G cells, or exposure of
these cells to irradiated cell-conditioned medium, signifi-
cantly altered mitochondrial oxygen consumption and in-
creased mitochondrial mass (151), as well as decreased
expression of mtDNA-associated genes (150).
mtDNA is an important target of the bystander effect.
Several reports indicate that mtDNA mutations (79) and de-
letions (79, 143, 185) occur upon exposure to the conditioned
medium from irradiated cells, with these mutations correlat-
ing with a decrease in mitochondrial membrane potential (79).
The bystander effect can also affect mtDNA gene expression
(35, 150). For instance, Chaudhry and Omaruddin (35) found
that in both X-irradiated and bystander TK6 human lym-
phoblast cells, there was a statistically significant change in
the expression of various mtDNA encoded genes for differ-
ent components of the electron transport chain. MT-ND1,
MT-ND5, and MT-ND6 (components of NADH dehydroge-
nase) were upregulated in directly-irradiated cells but were
downregulated in bystander cells, whereas MT-ATP6 and
MT-ATP8 were upregulated in both cell types (35).
Although cytochrome c (cytc) does not affect the direct re-
sponse of cells to ionizing radiation or the generation of by-
stander signals, it has a significant impact on response to
bystander signals from irradiated cells. Co-culture of mouse
embryonic fibroblasts (MEFs) that are cytc-null (cytc - / - )
with a-particle-irradiated cytc - / - or cytc + / + cells resulted in
no significant induction of micronuclei formation in cytc - / -
bystander cells. The conditioned medium from irradiated
cytc + / + or cytc - / - cells stimulated ROS production in cytc + / +
bystander cells, but not cytc - / - bystander cells (225).
Genomic DNA damage occurs in bystander cells as a result
of signaling events modulated by mitochondria. Telomere
shortening and anaphase bridge formation caused by incuba-
tion of bystander SW480 cells with the medium from explanted
tumor tissue exposed to c-rays correlated with a decrease in
mitochondrial membrane potential and an increase in ROS
formation. Overexpression of MnSOD in the SW480 cells not
only diminished the effects of the conditioned medium on
mitochondrial membrane potential and ROS formation, but
also significantly reduced the effects of the conditioned me-
dium on telomere shortening and anaphase bridge formation.
These results suggest that MnSOD may be important for in-
hibition of the bystander effect in nontarget cells (80).
Tumor Architecture and Its Effects
on Radiation Medicine
Tumors as organs
Long thought to be only a clonal expansion of mutated
cells, tumors are actually complex mixtures of various cell
types organized as abnormal organs. A variety of cells have
been identified in tumors, many of which contribute to tumor
progression, including adipocytes, fibroblasts, endothelial
cells, and myriad immune cells [reviewed in ref. (49)]. During
tumor progression, changes in the interactions between the
cancer cells and supporting cells, including cancer stem cells
[recently reviewed in ref. (26)], as well as the differences in
the interaction between cancer cells with extracellular matrix
(and the composition of the extracellular matrix) occur, which
can contribute to radiation resistance in tumors. For exam-
ple, Josson et al. (107) found that coculture of ARCaPE (with
an epithelial morphology and phenotype) human prostate
cancer cells with either bone fibroblasts or stromal fibroblasts
isolated from normal or cancer-bearing prostate tissue sig-
nificantly enhanced radioresistance of ARCaPE cells. This
radioprotective effect was mediated by both E-cadherin
and integrin signaling. Interestingly, coculture of ARCaPM
(with a mesenchymal morphology and phenotype) human
prostate cancer cells with bone or prostate fibroblasts did
not affect radioresistance (107), indicating an important role
for phenotype on cancer cell responsiveness. Coculture of
Suit-2 human pancreatic cancer cells with c-ray-treated MRC5
human fibroblast cells or primary pancreatic fibroblasts sig-
nificantly enhanced invasiveness both in vitro and in vivo.
Enhancement of Suit-2 invasiveness and cell scattering was
induced by incubation with the conditioned medium from
irradiated MRC5, coinciding with an increase in p44/p42
MAPK and c-Met activation, and was blocked by pretreat-
ment with the hepatocyte growth factor inhibitor NK4 (156).
In a study by Tsai et al., (206) coculture of MCF-7 or
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MDA-MB-231 human breast cancer cells with senescent primary
human mammary fibroblasts (induced by X-ray treatment)
significantly enhanced cell growth due to the stimulation of the
expression of mitotic genes. Senescent fibroblasts, as well as
senescent fibroblast-conditioned medium, also conferred radio-
resistance to the breast cancer cells, which was partially atten-
uated by expression of dominant-negative AKT in the breast
cancer cells (206). These results demonstrate the importance of
supporting cells for the response of cancer cells to ionizing ra-
diation. Because of the role of soluble factors secreted by the
supporting cells in conferring radioprotection and stimulation of
aggressiveness of cancer cells, the bystander effect may be vital
contributor of this process. Methods that target the bystander
effect between cancer cells and the supporting cells within the
tumor may prove attractive for enhancing the effectiveness of
radiation therapy.
Tumor hypoxia and radiation treatment
Given the importance of oxygen in the response of cells to
radiation (23, 82, 106), hypoxia becomes a major problem in
the treatment of tumors by radiation. Two types of hypoxia
exist in tumors: chronic and acute (Fig. 7). Chronic hypoxia
occurs due to the diffusion limits of oxygen through tissues,
whereas acute hypoxia occurs due to temporary blockage of a
tumor blood vessel (25). Chronic hypoxia was first identified
by Deschner and Gray, who found that oxygen supply to cells
within a tumor is limited to a region *150 lm from the vas-
culature (44). Acute hypoxia was first identified by Brown (24)
and can have important implications in the response of tu-
mors to radiation (32). Several reports show that radiosensi-
tivity of cancer cells is inversely proportional to the distance
from the blood supply (142, 201). Chaplin et al. discovered that
tumor cells closest to the blood vessels of the tumor were most
sensitive to ionizing radiation (as measured by clonogenic
survival), whereas the tumor cells farthest from the blood
vessel were most resistant to ionizing radiation. Ionizing ra-
diation resulted in acute hypoxia in the tumor due to transient
changes in blood flow, and this acute hypoxia increased
radioresistance in the tumor (33). Hsieh et al. compared the
influence of either cycling hypoxia or uninterrupted hypoxia
on radiation resistance of U87 glioma cells and found that
cycling hypoxia greatly increased U87 glioma cell radiation
resistance compared to uninterrupted hypoxia due to in-
creased ROS production, leading to greater stabilization, ex-
pression, and transcriptional activity of hypoxia-inducible
factor-1a (HIF-1a). Suppression of HIF-1a induction by siRNA
resulted in radiosensitization of U87 cells both in vitro and
in vivo (98).
Because hypoxia diminishes the effectiveness of radiation
therapy, several methods have been devised to increase oxy-
gen concentrations at the tumor. These methods include in-
creasing blood oxygen saturation, diminishing tumor oxygen
consumption (106), and normalization of tumor vasculature
(76). Secomb et al. (186) studied the effects of blood flow, ar-
terial pO2, and oxygen consumption on tumor cell hypoxia
using a simulation based on observations from a transplanted
mammary adenocarcinoma. While hypoxia was reduced with
increasing blood flow and arterial pO2 and decreased oxygen
consumption, tumors were much more sensitive to changes
in oxygen consumption, with a 30% reduction in oxygen
consumption, compared to controls, completely eliminating
tumor hypoxia (186). McGee et al. (136) studied the effects of
interferon-b (IFN-b) or the monoclonal human vascular en-
dothelial growth factor (VEGF) antibody bevacizumab, on
the radiation response of orthotopic U87 glioma xenografts.
IFN-b or bevacizumab decreased tumor hypoxia by normal-
ization of tumor vasculature. Combination of radiation with
either IFN-b or bevacizumab synergistically reduced tumor
size compared to any individual therapy alone, demonstrat-
ing the importance of tumor oxygenation by normalization of
vasculature in radiation therapy (136).
Another important method to treat tumors that can affect
tumor oxygenation is fractionated radiotherapy. By applying
radiation in a fractionated regimen, normal tissues can re-
cover through repair of sublethal damage and repopulation
of normal cells (10). Fractionated therapy takes advantage
of the increased proliferation rate in cancer cells compared to
FIG. 7. Hypoxia within a tumor. Two types of hypoxia
occur within a tumor: chronic hypoxia and acute hypoxia.
Chronic hypoxia occurs due to the diffusion limits of oxygen
from blood vessels. Acute hypoxia may be due to blockage of
blood flow in a region of the tumor. To see this illustration in
color, the reader is referred to the web version of this article
at www.liebertpub.com/ars
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normal tissues (15). Fractionation, especially hyperfractiona-
tion, permits a higher total radiation dose to be delivered.
Fractionated therapy also allows for the reoxygenation of
tumors and increases their radiosensitivity (Fig. 8) (137). The
combination of radiation with chemotherapy postradio-
therapy can enhance drug delivery and improve patient
outcome.
SODs in Normal and Tumor Tissues
General description of SODs
Because SODs are discussed in much greater detail in other
review articles in this Forum, we will only briefly describe
the SODs. SODs are the chief superoxide-scavenging en-
zymes in a cell (71), and three types exist in cells, with
each form encoded by a separate gene [reviewed in ref.
(228)]: CuZnSOD (SOD1), MnSOD (SOD2), and extracellular
superoxide dismutase (SOD3, ECSOD). CuZnSOD is a cyto-
plasmic homodimer (113, 135), although small amounts have
been identified in the intermembrane space of mitochondria
(157, 217). ECSOD shares 40–60% amino acid homology with
CuZnSOD, and like CuZnSOD, contains both copper and zinc
in its active site. However, ECSOD is a homotetramer found in
the extracellular region of the cell (68, 92). MnSOD is a
homotetramer found exclusively in the mitochondrial matrix
(19, 157, 179, 217, 220). All three enzymes catalyze the dis-
mutation of superoxide radicals to hydrogen peroxide and
molecular oxygen. Hydrogen peroxide, itself a ROS, is de-
composed to water by myriad enzyme systems, including
peroxiredoxins, glutathione peroxidase (GPx), and catalase
(4). All three enzymes have forms localized to mitochondria
(31, 62, 131, 155, 160, 177, 183, 188, 190) (Fig. 9).
SOD in cancer development
Given the role of ionizing radiation in the development of
cancer (46) and the significance of ROS in the development
and progression of cancer (75, 209, 215), the importance of
MnSOD in cancer development becomes quite evident due
to its ability to scavenge ROS. However, a careful examina-
tion of the literature reveals a dual function for MnSOD in
cancer [recently reviewed in ref. (94)]. Many studies show a
reduction in MnSOD expression in various types of cancer
compared to normal tissues (39, 42, 100, 153, 192), suggesting
MnSOD acts a tumor suppressor. Conversely, other studies
report an elevation in MnSOD expression in cancer (93, 99,
103, 104, 132, 203, 207) and its association with cancer ag-
gressiveness, growth, survival (140, 158), and metastatic po-
tential (95, 132, 149, 184), implying that MnSOD supports
progression of tumors to a more aggressive stage.
Recent work by this laboratory has begun to shed
light on the dual role of MnSOD in cancer development.
Using the 7,12-dimethylbenz(a)-anthracene (DMBA)/12-O-
tetradecanoylphorbol-13-acetate (TPA) two-stage model of
skin cancer development in a unique mouse model expressing
a MnSOD promoter-linked luciferase reporter gene (45), this
laboratory discovered that treatment with the tumor initiator
DMBA, followed by repeated exposure to TPA over 25 weeks,
resulted in a significant reduction in MnSOD luciferase re-
porter gene activity, MnSOD mRNA, protein, and enzyme
activity in both DMBA/TPA-treated skin and papillomas
compared to vehicle controls. When the observation period
was extended to allow squamous cell carcinoma (SCC) for-
mation, MnSOD expression significantly increased at the re-
porter gene activity, mRNA, protein, and enzyme activity
levels during the transition from the relatively nonaggressive
papilloma to the more aggressive SCC. These differences in
MnSOD expression between papillomas and SCCs are due, in
part, to changes in Sp1 and p53 transcription factor binding
activity on the Sod2 promoter (45).
One potential mechanism by which MnSOD is involved in
tumor suppression and tumor aggressiveness is altered hy-
drogen peroxide flux with changes in MnSOD levels. Buettner
et al. (27) showed that steady-state levels of hydrogen perox-
ide are affected by MnSOD where the equilibrium constant for
superoxide production (K) is less than 1. Under these condi-
tions, the rate constant for the back reaction (conversion of
superoxide back to molecular oxygen) is greater than the rate
constant for the forward reaction (conversion of molecular
oxygen to superoxide). This condition is seen for superoxide
production by the electron transport chain. When MnSOD is
present, there is a proportional increase in hydrogen peroxide
production with increasing MnSOD levels. The greatest effect
occurs when MnSOD levels are low, but at sufficiently high
levels of MnSOD, there is only a modest further increase in
hydrogen peroxide production. Increased hydrogen peroxide
production occurs because MnSOD is driving the equilibrium
of the system to the right, resulting in increased superoxide
FIG. 8. The effects of fractionated radiotherapy on tumors. Fractionated therapy allows the recovery and repair of normal
tissues and the reoxygenation of tumor tissues. Reoxygenation of the tumor increases the efficacy of radiation against the
tumor. To see this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars
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production. A small amount of superoxide is consumed for
the production of hydrogen peroxide and does not participate
in the reverse reaction to regenerate molecular oxygen, in
agreement with Le Chatelier’s principle (27).
Changes in hydrogen peroxide flux with modifications in
MnSOD levels can have broad repercussions in cancer pro-
gression. During early stages of cancer, when MnSOD levels
are low (153), MnSOD overexpression may suppress cancer
growth through various mechanisms because of greater hy-
drogen peroxide flux (126). At later stages of cancer progres-
sion, when cancer cells experience persistent oxidative stress
(16, 161, 168), increased MnSOD expression may benefit
cancer cells by the stimulation of metastasis (40, 90, 95, 147).
SOD in radiation-induced neoplastic transformation
Two important papers established the importance of SODs
in radiation-induced neoplastic transformation of normal
tissues. This laboratory was the first to demonstrate the pro-
tective effects of MnSOD overexpression in the protection of
normal tissue from ionizing radiation-induced neoplastic
transformation. In C3H 10T1/2 MEFs expressing either an
empty vector or a construct containing the Sod2 gene, St. Clair
et al. discovered that overexpression of MnSOD did not pro-
tect the cells from transformation by the DNA intercalating
agent 3-methylcholanthrene but did protect the cells from
transformation by ionizing radiation (194). Du et al., (48)
using MEFs derived from MnSOD + / + , MnSOD + / - , and
MnSOD - / - mice, found a fivefold increase in transformation
frequency in MnSOD - / - MEFs compared to MnSOD + / +
MEFs. The lack of MnSOD in MnSOD - / - MEFs enhanced the
formation of late ROS, micronuclei (a marker of DNA dam-
age), and binucleated bearing micronuclei cells at 72 h post-
irradiation compared to MnSOD + / - and MnSOD + / + MEFs.
MnSOD + / - and MnSOD - / - MEFs also demonstrated de-
creased exit from the G2 cell cycle checkpoint compared to
MnSOD + / + MEFs, which was reversed in MnSOD - / - cells
by overexpression of MnSOD (48). These results suggest that
mitochondrial ROS generation is an important component of
ionizing radiation-mediated transformation and the vital role
for MnSOD for the prevention of cancer formation.
SOD-mediated radioprotection
Many studies have revealed the importance of SOD in pro-
tection of normal tissue from the harmful effects of ionizing
radiation. Lee et al. (121) used a yeast model with knockdown
of MnSOD, CuZnSOD, or both MnSOD and CuZnSOD, to
study radiation response. The researchers found that in wild-
type cells, there was a dose-dependent increase in the activity
of different antioxidant enzymes (catalase, glutathione reduc-
tase, and glucose 6-phosphate dehydrogenase), whereas
knockdown of either SOD alone or the combination of MnSOD
and CuZnSOD resulted in a much smaller increase in the ac-
tivities of these enzymes. The researchers also found a radiation
dose-dependent increase in the levels of ROS and ROS-medi-
ated protein and lipid damage (protein carbonyl formation and
thiobarbituric acid-reactive substances, respectively) (121).
Overexpression of MnSOD alone is enough to bestow ra-
dioprotection in normal cells. In CHO cells, overexpression
of MnSOD, but not CuZnSOD, protected the cells from
radiation-induced cell death. Overexpression of GPx was only
partially protective against radiation compared to MnSOD
(195). Overexpression of MnSOD by retroviral transduction in
either K562 human erythroleukemic cells or primary mouse
bone marrow-derived myeloid progenitor cells resulted in a
significant increase in radioresistance (193). MnSOD is also
important for radiation-induced adaptive response in normal
cells. In JB6 mouse epidermal cells, exposure to low-dose
ionizing radiation significantly increased the clonogenic sur-
vival of cells subsequently challenged to 2 Gy radiation due to
activation of several NF-jB target genes, including MnSOD
(63). An important mechanism by which MnSOD confers ra-
dioprotection of normal tissues is to prevent apoptosis (50,
56), in part, by maintaining mitochondrial integrity (56).
These results suggest that mitochondria are major targets of
ionizing radiation and mitochondria-specific scavenging of
ROS by MnSOD may be an important mechanism to safe-
guard cells against radiation-induced damage.
CuZnSOD also has a radioprotective effect in normal tis-
sue. Petkau et al. found that the administration of mice with
bovine SOD by intravenous injection before and after ionizing
radiation treatment significantly increased the LD50 dose (164,
165), and exogenous SOD protected the proliferative capacity
of bone marrow stem cells from ionizing radiation, indicating
a protective effect of SOD (164). The addition of CuZnSOD
either before irradiation or after irradiation also had a protec-
tive effect in HUVEC, although pretreatment with CuZnSOD
gave the greatest level of radioprotection. CuZnSOD pretreat-
ment also partially attenuated the antiangiogenic effects of
FIG. 9. Sources and means of detoxification of ROS in the
cell. Superoxide radicals are generated at different sites in the
cell, such as the ER, ETC in mitochondria, as well as various
enzymatic sources, like NOX and XO, all of which contribute to
the generation of ROS after ionizing radiation. Superoxide
radicals are detoxified by SODs to form hydrogen peroxide,
which is further detoxified by GPx and Prx. GR is used to
regenerate GSH. ER, endoplasmic reticulum; ETC, electron
transport chain; GPx, glutathione peroxidase; GR, glutathione
reductase; GSH, reduced glutathione; NOS, NADPH oxidase;
Prx, peroxiredoxin; SOD, superoxide dismutase; XO, xanthine
oxidase. To see this illustration in color, the reader is referred to
the web version of this article at www.liebertpub.com/ars
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radiation, as determined by tube formation of HUVEC cells
in vitro. The radioprotective effect of CuZnSOD leading to in-
creased angiogenesis required the activation of the mitogen-
activated protein/extracellular signal-regulated kinase1/2
pathway, and the pretreatment of HUVECs with the MEK in-
hibitor PD98059 suppressed the effects of CuZnSOD (204).
ECSOD, like MnSOD and CuZnSOD, confers protection
from the harmful effects of ionizing radiation. Lung-specific
overexpression of ECSOD in B6C3 mice resulted in a signifi-
cant reduction in radiation-induced lung damage compared
to wild-type mice. For example, ECSOD overexpression de-
layed the onset of increased breathing frequency and sig-
nificantly reduced breathing rate compared to irradiated
wild-type mice. ECSOD also reduced radiation-induced in-
creases in macrophage and lymphocyte lung infiltration
compared to irradiated wild-type mice, as well as decreased
TGFb activation, Smad3 expression, and Smad2/3 activation
and reduced lipid peroxidation (111, 174).
While a multitude of studies show a role for SOD in radio-
protection of normal tissue, other studies suggest an apparent
radiosensitization effect. Fishman et al. (67) discovered that
knockdown of either MnSOD or CuZnSOD in C57BL/6J mice
attenuated radiation-induced reductions in neuronal cells and
cells differentiated into either neurons, astrocytes, or microglia in
the dentate subgranular zone of the hippocampus compared to
wild-type mice. The authors suggest that one potential mecha-
nism of the protective effect of MnSOD or CuZnSOD knock-
down may be increased superoxide levels. This hypothesis was
supported by experiments using xanthine or xanthine plus
xanthine oxidase. Incubation of neural precursor cells with either
xanthine alone or xanthine/xanthine oxidase had a protective
effect against radiation-induced diminution of cell numbers.
Although the authors did not address the specific mechanisms
by which decreased SOD, whether MnSOD or CuZnSOD, im-
parted a radioprotective effect on neuronal cells, they suggested
that the effect may be similar to an adaptive response for radi-
ation, whereby low doses of ionizing radiation are protective
against later, high doses of ionizing radiation (67). It would be
interesting to determine whether the observed effect of SOD
knockdown can occur in other normal cells and tumor cells.
SOD and Radiation Response in Neoplastic Cells
Radiosensitization
Using the MnSOD-overexpressing Fsa-II cells implanted in
mice, this laboratory found that MnSOD expression resulted
in a significant reduction in the radiation dose required
to control one-half of the irradiated tumors compared to
control mice (208). Overexpression of MnSOD by transfection
with a MnSOD cDNA-expressing plasmid/liposome complex
(MnSOD-PL) proved effective in increasing radiosensitivity
of SCC-VII mouse SCC cells (D0 = 1.244 Gy compared to
3.246 Gy for control cells), and the combination of MnSOD-PL
with the EGFR inhibitor gefitinib further increased radio-
sensitization (D0 = 0.785 Gy) (54). The administration of re-
combinant MnSOD (rMnSOD) was also effective in enhancing
radiosensitivity of cancer cells (20).
Radioresistance
Although some studies suggest a radiosensitizing role for
MnSOD, other studies show that MnSOD is important in
radioresistance of cancer cells. Qu et al. (172, 173) found that the
CNE1 human nasopharyngeal cell line was more radioresistant
than the CNE2 cell line, which correlated with increased ex-
pression and activity of MnSOD in the CNE1 cell line.
Knockdown of MnSOD in CNE1 cells decreased radio-
resistance (172, 173). Feng et al. generated a radioresistant
CNE2 cell line (CNE2-IR) by treating parental CNE2 cells with
five rounds of sublethal IR. Gene expression between CNE2
and CNE2-IR cells was compared, and there was an increase in
MnSOD expression, among other genes, in the radioresistant
cell line (64). MnSOD expression correlated well with radio-
resistance in nasopharyngeal tumors (64, 172), suggesting that
MnSOD may be predictive in determining radioresistance of
tumors. An important mechanism of radioresistance is cell
cycle arrest at the G2 phase of the cell cycle after exposure (66,
109). Scavenging of hydrogen peroxide by catalase expression
or treatment with NAC abolished MnSOD-induced radio-
resistance (199). Using a systems biology approach, Niciforovic
et al. discovered that radioresistance was associated with a
positive feed-forward cycle with hydrogen peroxide-induced
elevation of MnSOD expression (148).
MnSOD is a major target gene for the NF-jB pathway (116,
117, 223). The NF-jB pathway is vital for conferring radiation
resistance in cancer cells (124), and a major mechanism of
NF-jB-dependent radioresistance is induction of MnSOD
[reviewed in ref. (96)]. For example, Guo et al. (84) discovered
that MnSOD expression was significantly increased as part of
a radioadaptive response in MCF-7 human breast cancer cells.
This radioresistance was replicated by stable overexpression
of MnSOD, and several NF-jB target genes important for
survival were expressed in both radioadapted cells and cells
overexpressing MnSOD (84). Work by this laboratory has
focused on the mechanisms by which the alternative NF-jB
pathway increases radioresistance in prostate cancer cells. In a
study by Josson et al., (108) nuclear localization of RelB
(a component of the alternative NF-jB pathway) (187) was
significantly higher in aggressive PC-3 human prostate cells
compared to LNCaP cells and correlated with increased
MnSOD expression and radioresistance (108). Inhibition of
the alternative NF-jB pathway by expression of RelB-specific
siRNA, overexpression of a dominant-negative p100 (108),
treatment with the peptide inhibitor SN52 (to prevent nu-
clear translocation of RelB) (222), or administration of 1a,25-
dihyroxyvitamin D3 (to inhibit RelB expression) (221), all
resulted in a decrease in radiation-induced MnSOD expres-
sion and an increase in radiosensitivity in PC-3 cells.
CuZnSOD can also confer radioresistance in cancer cells.
Gao et al. (72) reported that the overexpression of CuZnSOD
in U118-9 human glioma cells increased radioresistance
compared to vector control and parental cells. ROS accumu-
lation occurred in parental and vector control cells starting at
2 days postirradiation and remained elevated up to 8 days
after radiation. This late accumulation of ROS was suppressed
in CuZnSOD-overexpressing cells. CuZnSOD overexpression
also increased the accumulation of the cells at the G2 phase of
the cell cycle, as well as decreased cyclin B1 expression (72).
SODs are a double-edged sword
in the radiation response of cancer cells
The studies highlighted above suggest a more complicated
role for SODs in the response of cancer cells to ionizing
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radiation. This dual role for SODs may be due to differences in
the expression and/or activity of other antioxidant enzymes
in various types of cancer cells. For example, well-differentiated
hepatocellular carcinoma cell lines have higher activity or ex-
pression levels of catalase, glutathione reductase, CuZnSOD,
and MnSOD compared to poorly differentiated cell lines
(227). In patients with renal cell carcinoma, there was a sig-
nificant reduction in the activity of GPx and catalase in cancer
tissues compared to normal tissues (166). On the other hand,
other studies have demonstrated an elevation in the expres-
sion and activity of some antioxidant enzymes in cancer cells.
Increased expression of MnSOD and catalase were observed
in gastric carcinoma cells compared to noncancerous cells
(101), and increased MnSOD expression was associated with
lymph node metastasis in gastric cancer patients (132).
Overexpression of SODs in cancer cells expressing low levels
of other antioxidant enzymes that remove hydrogen peroxide
may have a radiosensitization effect, perhaps because of in-
creased hydrogen peroxide levels after irradiation. Con-
versely, overexpression of SODs in cancer cells with high
levels of hydrogen peroxide-scavenging enzymes may have a
radioresistant effect because of increased dismutation of su-
peroxide radicals generated after irradiation and the ability to
handle the resultant increase in hydrogen peroxide produced.
Given the dual effect of SODs on the response of cancer
cells to ionizing radiation, careful screening of the antioxidant
status of tumor tissues should be considered before embark-
ing on the use of SOD therapy in parallel with radiation
therapy. This screening of tumor tissues may include ex-
pression of different antioxidant enzymes alone, or even ratios
of different enzymes, as well as a comparison of antioxidant
enzyme expression between tumor and normal tissues. This
approach would better tailor the therapy to each patient and
maximize the effectiveness of the therapy to destroy cancer
tissue and mitigate normal tissue injury.
Methods Exploiting SOD for Radiation Response
Because of the detrimental effects of ionizing radiation on
normal tissues, the resistance of tumor tissues to radiation
therapy, and the role of ROS in these processes, methods that
can increase SOD expression and/or activity may prove to be
important adjuvants to radiotherapy to increase radiosensi-
tivity in tumor tissues and protect normal tissues. An impor-
tant mechanism for the effects of SOD overexpression on the
simultaneous radioprotection of normal tissues and radio-
sensitization of tumor tissues may be diminished expression of
other antioxidant enzymes, especially catalase, in most cancer
tissues compared to normal tissues (9, 20, 21, 41, 154, 196, 197).
These enzymes catalyze the decomposition of hydrogen per-
oxide to molecular oxygen and water. Cancer cells are under
higher levels of oxidative stress than nontumorigenic cells (91,
153). Therefore, overexpression of SODs in cancer cells may set
up a condition whereby exposure to ionizing radiation results
in a greater ROS insult than in normal tissues, resulting in
greater cell death and cell cycle arrest. In contrast, over-
expression of SODs in normal tissues is radioprotective because
of the increased antioxidant capacity in normal tissues to
handle the ROS burst resulting from radiation exposure. Dis-
cussed below are several strategies that have been devised to
increase SOD activity and/or expression in vivo for modulation
of the radiation response in normal and tumor tissues.
Overexpression of SOD
Plasmid/liposome therapy. MnSOD-PL are useful for in-
creasing the expression of MnSOD in tissues. This particular
approach has proven effective in protecting lung tissue (29, 53,
57), the oral cavity (52, 85), and the esophagus (55, 58) from
ionizing radiation-induced damage. Interestingly, this therapy
also simultaneously sensitizes cancer cells to ionizing radiation.
For example, Epperly et al. (50) discovered that the over-
expression of MnSOD using MnSOD-PL inhibited radiation-
induced GPx expression in SCC-VII murine and OC-19 human
SCC cells and 3LL murine lung carcinoma cells and increased
radiosensitization of SCC-VII and OC-19 cells, but did not af-
fect the radiosensitivity of 3LL cells, in vitro. In MEFs, radiation
had no effect on GPx activity, but significantly reduced re-
duced glutathione (GSH) levels, and the administration of
MnSOD-PL significantly increased GSH levels after irradiation,
suggesting a radioprotective effect on normal cells in vitro.
In vivo, the administration of MnSOD-PL had no effect on
radiation-induced reduction in GSH in oral cavity SCC-VII
orthotopic tumor tissue, but significantly reduced GPx activity
in conjunction with radiation. In adjacent normal oral mucosal
tissue, MnSOD-PL protected from radiation-induced changes
in GSH levels and GPx activity (59). Intraoral administration
of the MnSOD-PL therapy significantly decreased the num-
ber of ulcerations 5 days after irradiation compared to irradi-
ated control mice. Interestingly, the administration of the
MnSOD-PL therapy did not protect SCC-VII tumors from the
effects of radiation (85). These results suggest a potential for
radioprotection of normal tissue and radiosensitization of tu-
mor tissue by MnSOD-PL.
Virus-mediated overexpression. The use of viruses is
another efficient method for overexpression of MnSOD to
alter radiation response. Adenovirus-mediated over-
expression of MnSOD, both in vitro (234) and in vivo (51),
confers protection to lung tissue and lung epithelial cells
against radiation-induced damage. For example, intratracheal
injection of MnSOD adenovirus significantly decreased al-
veolitis, in part, by suppressing radiation-induced expression
of different inflammatory cytokines (transforming growth
factor-beta [TGF-b], TNF-a, and interleukin-1) (51). Retroviral
transduction of a MnSOD construct in hematopoietic cells
protected the cells from ionizing radiation-induced DNA
damage both in vitro and in vivo (193). Intraluminal admin-
istration of a herpes simplex virus-MnSOD virus had a ra-
dioprotective effect on the small intestine (86). Transfection
of urothelia (bladder) with MnSOD transgene did not protect
bladders from the acute effects of radiation early after expo-
sure (as measured by transepithelial resistance and perme-
abilities to water and urea) but did enhance recovery at 4
weeks after irradiation compared to controls (110). These re-
sults suggest a persistent effect of ionizing radiation on oxi-
dative metabolism lasting for weeks after radiotherapy and
the ability of SOD overexpression to ameliorate this effect.
Recombinant protein
Administration of a recombinant form of MnSOD can also be
radioprotective. Borrelli et al. (20) found that treatment with
rMnSOD sensitized cancer cells to ionizing radiation and pro-
tected normal cells from ionizing radiation in vitro. In vivo, in-
traperitoneal administration of rMnSOD after irradiation, with
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subsequent rMnSOD treatments for an additional 6 days, sig-
nificantly diminished radiation-induced organ damage and
increased survival compared to animals receiving phosphate-
buffered saline only (20).
SOD mimetics
Another attractive approach to increase the SOD activity
in normal tissue and cancer is the use of SOD mimetics. Sev-
eral manganese porphyrin compounds, as well as non-metal-
based compounds, have been developed with variable
superoxide-scavenging properties, pharmacokinetics and
tissue and subcellular localization (11, 138), and several of
these porphyrin-based mimetics (Fig. 10) are effective in de-
creasing radiation-induced damage in normal tissue and
radiosensitizing tumor tissue.
Mn(III) 5,10,15,20-tetrakis(N-ethylpyridinium-2-yl)porphyrin
(MnTE-2-PyP5 + ) protects from bone marrow suppression
induced by total body irradiation by inhibiting oxidative
damage induced by ionizing radiation in hematopoietic stem
cells and progenitor cells (125). MnTE-2-PyP5 + has also pro-
ven effective in delaying the onset of ionizing radiation-
induced lung injury in rats, as indicated by diminished
breathing frequency, reduced lung fibrosis, and less hydro-
xyproline content (indicating collagen deposition) compared to
irradiated rats receiving no mimetic (212). MnTE-2-PyP5 + de-
creased oxidative stress, blocked the activation of HIF-1a and
TGF-b, and suppressed the upregulation of carbonic anhy-
drase-IX and VEGF expression. The protective effect of MnTE-
2-PyP5 + can also occur long after the irradiation event. The
administration of MnTE-2-PyP5 + at 3 days and 8 weeks post-
irradiation, while not affecting radiation-induced oxidative
DNA damage, significantly reduced histopathological damage
in the lungs compared to animals not receiving mimetic (74).
While MnTE-2-PyP5 + is effective in radioprotection of
normal tissues, Mn(III) 5,10,15,20-tetrakis(N-hexylpyridinium-
2-yl)porphyrin (MnTnHex-2-PyP5 + ) has been proven to be
even more efficacious than MnTE-2-PyP5 + due to its greater
lipophilicity and higher biodistribution (218). At high con-
centrations, MnTnHex-2-PyP5 + can cause toxicity, which may
be due to its micellar properties (73). Another SOD mimetic
useful in suppressing radiation-induced lung damage after
both single-dose (175) and fractionated radiotherapy (176)
is Mn(III) tetrakis(N,N¢-diethylimidazolium-2-yl)porphyrin
(AEOL 10150). Potential mechanism of diminution of radia-
tion-induced lung damage include reduction in inflammatory
cytokines in both plasma (212) and lung tissue (74), suppres-
sion of oxidative DNA and protein damage (176), as well as a
decrease in radiation-induced apoptosis (224).
Not only do SOD mimetics have radioprotective effects on
normal tissues, but they can also have radiosensitization ef-
fects on cancerous tissues. Moeller et al. (139) found that the
SOD mimetic MnTE-2-PyP5 +, at all doses tested, was not cy-
totoxic on the different tumor and endothelial cell lines tested
and neither sensitized nor protected the cells from radiation
treatment in vitro. Interestingly, MnTE-2-PyP5 + inhibited the
radioprotective effects of tumor cell-conditioned medium on
endothelial cells in vitro and enhanced radiation-induced
damage to tumor vasculature and delayed tumor growth
in vivo (139), suggesting that SOD mimetics may disrupt
communication between tumor and endothelial cells, leading
to breakdown of tumor vasculature after radiation and dis-
ruption of the tumor microenvironment.
Concluding Remarks
Ionizing radiation is an efficient method for the treatment of
cancer. However, the development of normal tissue injury can
limit the effectiveness of radiotherapy. ROS are important me-
diators of radiation therapy and can also participate in the dif-
ferential effect of radiation in cancer cells and in normal cells due
to differences in the antioxidant potential between tumor and
normal tissues. Bystander effects play an important role in the
response of cancerous and normal tissues to ionizing radiation,
FIG. 10. Various SOD mimetics used in studies on radiotherapy in vivo. All three mimetics discussed in this article have
the same porphyrin core and differ only in the substituents on porphyrin. AEOL 10150 contain N,N¢-diethylimidazolium,
whereas MnTE-2-PyP5 + and MnTnHex-2-PyP5 + contain an ethyl and hexyl hydrocarbon chain, respectively, on the nitrogen of
the pyridine ring. AEOL 10150, Mn(III) tetrakis(N,N¢-diethylimidazolium-2-yl)porphyrin; MnTE-2-PyP5 + , Mn(III) 5,10,15,20-
tetrakis(N-ethylpyridinium-2-yl)porphyrin; MnTnHex-2-PyP5 + , Mn(III) 5,10,15,20-tetrakis(N-hexylpyridinium-2-yl)porphyrin.
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potentially leading to radioresistance of cancer cells and radio-
sensitization of normal cells. ROS are key mediators of radiation-
induced bystander effects. Bystander effects are also important
for the effects of tumor microenvironment on radiation respon-
siveness, with communication between tumor and stromal cells
conferring radioprotection and increased aggressiveness of
tumor cells. SODs, the main ROS scavengers of the cell, play a
complex role in the response of cancer cells to ionizing radiation.
Increasing the expression and/or activity of SODs, especially
MnSOD, through the use of gene-expressing plasmid delivery
systems, viral vectors, administration of recombinant protein,
or the use of SOD mimetics, can increase the radiosensitivity of
cancer cells while simultaneously increasing the resistance of
normal tissues to radiation-induced injury in vivo. Development
of these techniques for use in humans may provide unique tools
for the radiation oncologist to improve treatment efficacy and
enhance the quality of life for cancer patients in the future.
Acknowledgments
The authors thank Mr. Tom Dolan and Mr. Matt Hazzard
of the Graphics and Multimedia/Academic Technology
Group at the University of Kentucky for their assistance in
generating the figures used in this article. This work was
supported by NIH grants 2T32ES007266 and CA143428.
References
1. Grupen C. Biological effects of ionizing radiation. In: In-
troduction to Radiation Protection, edited by Grupen C. Hei-
delberg, Germany: Springer-Verlag. 2010, pp. 212–228.
2. Adam-Vizi V and Chinopoulos C. Bioenergetics and the
formation of mitochondrial reactive oxygen species. Trends
Pharmacol Sci 27: 639–645, 2006.
3. Adriaens I, Smitz J, and Jacquet P. The current knowledge
on radiosensitivity of ovarian follicle development stages.
Human Reprod Update 15: 359–377, 2009.
4. Andreyev AY, Kushnareva YE, and Starkov AA. Mi-
tochondrial metabolism of reactive oxygen species. Bio-
chemistry (Moscow) 70: 246–264, 2005.
5. Asaithamby A, Hu B, and Chen DJ. Unrepaired clustered
DNA lesions induce chromosome breakage in human cells.
Proc Natl Acad Sci U S A 108: 8293–8298, 2011.
6. Autsavapromporn N, de Toledo SM, Buonanno M, Jay-
Gerin J-P, Harris AL, and Azzam EI. Intercellular
communication amplifies stressful effects in high-charge
high-energy (HZE) particle-irradiated human cells. J Radiat
Res 52: 408–414, 2011.
7. Autsavapromporn N, de Toledo SM, Little JB, Jay-Gerin J-
P, Harris AL, and Azzam EI. The role of gap junction
communication and oxidative stress in the propagation of
toxic effects among high-dose a-particle-irradiated human
cells. Radiat Res 175: 347–357, 2011.
8. Azzam EI, de Toledo SM, and Little JB. Direct evidence for
the participation of gap juction-mediated intecellular com-
munication in the transmission of damage signals from a-
particle irradiated to nonirradiated cells. Proc Natl Acad Sci
U S A 98: 473–478, 2001.
9. Balasubramaniyan N, Subramanian S, and Govindasamy S.
Status of antioxidant systems in human carcinoma of
uterine cervix. Cancer Lett 87: 187–192, 1994.
10. Baskar R, Lee KA, Yeo R, and Yeoh K-W. Cancer and ra-
diation therapy: current advances and future directions. Int
J Med Sci 9: 193–199, 2012.
11. Batinic-Haberle I, Reboucas JS, and Spasojevic I. Superoxide
dismutase mimics: chemistry, pharmacology, and thera-
peutic potential. Antioxid Redox Signal 13: 877–918, 2010.
12. Begg AC, Steward FA, and Vens C. Strategies to improve
radiotherapy with targeted drugs. Nat Rev Cancer 11: 239–
253, 2011.
13. Belloni P, Latini P, and Palitti F. Radiation-induced by-
stander effect in healthy G0 human lymphocytes: biological
and clinical significance. Mutat Res 713: 32–38, 2011.
14. Belyakov OV, Malcolmson AM, Folkard M, Prise KM, and
Michael BD. Direct evidence for a bystander effect of ion-
izing radiation in primary human fibroblasts. Br J Cancer
84: 674–679, 2001.
15. Bernier J, Hall EJ, and Giaccia A. Radiation oncology: a
century of achievements. Nat Rev Cancer 4: 737–747, 2004.
16. Biaglow JE and Miller RA. The thioredoxin reductase/
thioredoxin system: novel redox targets for cancer therapy.
Cancer Biol Ther 4: 6–13, 2005.
17. Blyth BJ and Sykes PJ. Radiation-induced bystander effects:
what are they, and how relevant are they to human radi-
ation exposures? Radiat Res 176: 139–157, 2011.
18. Boonstra J and Post JA. Molecular events associated with
reactive oxygen species and cell cycle progression in
mammalian cells. Gene 337: 1–13, 2004.
19. Borgstahl GEO, Parge HE, Hickey MJ, Beyer WF Jr.,
Hallewell RA, and Tainer JA. The structure of human mi-
tochondrial manganese superoxide dismutase reveals a
novel tetrameric interface of two 4-helix bundles. Cell 71:
107–118, 1992.
20. Borrelli A, Schiattarella A, Mancini R, Morrica B, Cerciello V,
Mormile M, d’Alesio V, Bottalico L, Morelli F, D’Armiento
M, D’Armiento FP, and Mancini A. A recombinant MnSOD
is radioprotective for normal cells and radiosensitizing for
tumor cells. Free Radic Biol Med 46: 110–116, 2009.
21. Bostwick DG, Alexander EE, Singh R, Shan A, Qian J,
Santella RM, Oberley LW, Yan T, Zhong W, Jiang X, and
Oberley TD. Antioxidant enzyme expression and reactive
oxygen species damage in prostatic intraepithelial neopla-
sia and cancer. Cancer 89: 123–134, 2000.
22. Brand MD. The sites and topology of mitochondrial su-
peroxide production. Exp Gerontol 45: 466–472, 2010.
23. Broerse JJ, Barendsen GW, and van Kersen GR. Survival of
cultured human cells after irradiation with fast neutrons of
different energies in hypoxic and oxygenated conditions.
Int J Radiat Biol 13: 559–572, 1968.
24. Brown JM. Evidence for acutely hypoxic cells in mouse
tumours, and a possible mechanism of reoxygenation. Br J
Radiol 52: 650–656, 1979.
25. Brown JM. Tumor hypoxia, drug resistance, and metasta-
ses. J Natl Cancer Inst 82: 338–339, 1990.
26. Brunner TB, Kunz-Schughart LA, Grosse-Gehling P, and
Baumann M. Cancer stem cells as a predictive factor in
radiotherapy. Semin Radiat Oncol 22: 151–174, 2012.
27. Buettner GR, Ng CF, Wang M, Rodgers VGJ, and Schafer
FQ. A new paradigm: manganese superoxide dismutase
influences the production of H2O2 in cells and thereby their
biological state. Free Radic Biol Med 41: 1338–1350, 2006.
28. Calveley VL, Khan MA, Yeung IWT, Vandyk J, and Hill
RP. Partial volume rat lung irradiation: temporal fluctua-
tions of in-field and out-of-field DNA damage and in-
flammatory cytokines following irradiation. Int J Radiat Biol
81: 887–899, 2005.
29. Carpenter M, Epperly MW, Agarwal A, Nie S, Hricisak L,
Niu Y, and Greenberger JS. Inhalation delivery of manganese
1582 HOLLEY ET AL.
superoxide dismutase-plasmid/liposomes protects the
murine lung from irradiation damage. Gene Ther 12: 685–
693, 2005.
30. Chai Y and Hei TK. Radiation induced bystander effect in
vivo. Acta Med Nagasaki 53: S65–S69, 2008.
31. Chang T-S, Cho C-S, Park S, Yu S, and Kang SW. Perox-
iredoxin III, a mitochondrion-specific peroxidase, regulate
apoptotic signaling by mitochondria. J Biol Chem 279:
41975–41984, 2004.
32. Chaplin DJ, Durand RE, and Olive PL. Acute hypoxia in
tumors: implications for modifiers of radiation effects. Int J
Radiat Oncol Biol Phys 12: 1279–1282, 1986.
33. Chaplin DJ, Olive PL, and Durand RE. Intermittent blood
flow in a murine tumor: radiobiological effects. Cancer Res
47: 597–601, 1987.
34. Chaudhry MA. Bystander effect: biological endpoints and
microarray analysis. Mutat Res 597: 98–112, 2006.
35. Chaudhry MA and Omaruddin RA. Mitochondrial gene
expression in directly irradiated and nonirradiated bystander
cells. Cancer Biother Radiopharmaceut 26: 657–663, 2011.
36. Chen S, Zhao Y, Chiu SK, Zhu L, Wu L, and Yu KN. Rescue
effects in radiobiology: unirradiated bystander cells assist
irradiated cells through intercellular signal feedback. Mutat
Res 706: 59–64, 2011.
37. Chen S, Zhao Y, Han W, Zhao G, Zhu L, Wang J, Bao L,
Jiang E, Xu A, Hei TK, Yu Z, and Wu L. Mitochondria-
dependent signalling pathway are involved in the early
process of radiation-induced bystander effects. Br J Cancer
98: 1839–1844, 2008.
38. Chen S, Zhao Y, Zhao G, Han W, Zao L, Yu KN, and Wu L.
Up-regulation of ROS by mitochondria-dependent by-
stander signaling contributes to genotoxicity of bystander
effects. Mutat Res 666: 68–73, 2009.
39. Chuang T-C, Liu J-Y, Lin C-T, Tang Y-T, Yeh M-H, Chang
S-C, Li J-W, and Kao M-C. Human manganese superoxide
dismutase suppresses HER2/neu-mediated breast cancer
malignancy. FEBS Lett 581: 4443–4449, 2007.
40. Connor KM, Hempel N, Nelson KK, Dabiri G, Gamarra A,
Balarmino J, van de Water L, Mian BM, and Melendez JA.
Manganese superoxide dismutase enhances the invasive
and migratory activity of tumor cells. Cancer Res 67: 10260–
10267, 2007.
41. Cullen JJ, Mitros FA, and Oberley LW. Expression of anti-
oxidant enzymes in diseases of the human pancreas: an-
other link between chronic pancreatitis and pancreatic
cancer. Pancreas 26: 23–27, 2003.
42. Cullen JJ, Weydert C, Hinkhouse MM, ritchie J, Domann
FE, Spitz D, and Oberley LW. The role of manganese su-
peroxide dismutase in the growth of pancreatic adenocar-
cinoma. Cancer Res 63: 1297–1303, 2003.
43. Delaney G, Jacob S, Featherstone C, and Barton M. The role
of radiotherapy in cancer treatment: estimating optimal
utilization from a review of evidence-based clinical guide-
lines. Cancer 104: 1129–1137, 2005.
44. Deschner EE and Gray LH. Influence of oxygen tension
on x-ray-induced chromosomal damage in Ehrlich ascites
tumor cells irradiated in vitro and in vivo. Radiat Res 11:
115–146, 1959.
45. Dhar SK, Tangpong J, Chaiswing L, Oberley TD, and St.
Clair DK. Manganese superoxide dismutase is a p53-regu-
lated gene that switches cancers between early and ad-
vanced stages. Cancer Res 71: 6684–6695, 2011.
46. Diallo I, Haddy N, Adjadj E, Samand A, Quiniou E, Cha-
vaudra j, Alziar I, Perret N, Guerin S, Lefkopoulos D, and
de Vathaire F. Frequency distribution of second solid can-
cer locations in relation to the irradiated volume among 115
patients treated for childhood cancer. Int J Radiat Oncol Biol
Phys 74: 876–883, 2009.
47. Droge W. Free radicals in the physiological control of cell
function. Physiol Rev 82: 47–95, 2002.
48. Du C, Gao Z, Venkatesha VA, Kalen AL, Chaudhuri L, Spitz
DR, Cullen JJ, Oberley LW, and Goswami PC. Mitochondrial
ROS and radiation induced transformation in mouse em-
bryonic fibroblasts. Cancer Biol Ther 8: 1962–1971, 2009.
49. Egeblad M, Nakasone ES, and Werb Z. Tumors as organs:
complex tissues that interface with the entire organism. Dev
Cell 18: 884–901, 2010.
50. Epperly MW, Bray JA, Esocobar P, Bigbee WL, Watkins S,
and Greenberger JS. Overexpression of the human man-
ganese superoxide dismutase (MnSOD) transgene in sub-
clones of murine hematopoietic progenitor cell line 32D cl 3
decreases irradiation-induced apoptosis but does not alter
G2/M or G1/S phase cell cycle arrest. Radiat Oncol Investig
7: 331–342, 1999.
51. Epperly MW, Bray JA, Krager S, Berry LM, Gooding W,
Engelhardt JF, Zwacka R, Travis EL, and Greenberger JS.
Intratracheal injection of adenovirus containing the human
MnSOD transgene protects athymic nude mice from irra-
diation-induced organizing alveolitis. Int J Radiat Oncol Biol
Phys 43: 169–181, 1999.
52. Epperly MW, Carpenter M, Agarwal A, Mitra P, Nie S, and
Greenberger JS. Intraoral manganese superoxide dis-
mutase-plasmid/liposome (MnSOD-PL) radioprotective
gene therapy decreases ionizing irradiation-induced mu-
rine mucosal cell cycling and apoptosis. In Vivo 18: 401–410,
2004.
53. Epperly MW, Epstein CJ, Travis EL, and Greenberger JS.
Decreased pulmonary radiation resistance of manganese
superoxide dismutase (MnSOD)-deficient mice is corrected
by human manganese superoxide dismtuase-plasmid/li-
posome (SOD2-PL) intratracheal gene therapy. Radiat Res
154: 365–374, 2000.
54. Epperly MW, Franicola D, Zhang X, Nie S, and Green-
berger JS. Effect of EGFR antagonists gefitinib (Iressa) and
C225 (Cetuximab) on MnSOD-plasmid liposome transgene
radiosensitization of a murine squamous cell carcinoma cell
line. In Vivo 20: 791–796, 2006.
55. Epperly MW, Gretton JA, DeFilippi SJ, Sikora CA, Liggitt
D, Koe G, and Greenberger BA. Modulation of radiation-
induced cytokine elevation associated with esophagitis and
esophageal stricture by manganese superoxide dismutase-
plasmid/liposome (SOD2-PL) gene therapy. Radiat Res 155:
2–14, 2001.
56. Epperly MW, Sikora CA, DeFilippi SJ, Gretton JE, Zhan Q,
Kufe DW, and Greenberger JS. Manganese superoxide
dismutase (SOD2) inhibits radiation-induced apoptosis by
stabilization of the mitochondrial membrane. Radiat Res
157: 568–577, 2002.
57. Epperly MW, Travis EL, Whitsett JA, Raineri I, Epstein CJ,
and Greenberger JS. Overexpression of manganese super-
oxide dismutase (MnSOD) in whole lung or alveolar type II
cells of MnSOD transgenic mice does not provide intrinsic
lung irradiation protection. Int J Cancer (Radiat Oncol Invest)
96: 11–21, 2001.
58. Epperly MW, Tyurina YY, Nie S, Niu YY, Zhang X, Kagan
VE, and Greenberger JS. MnSOD-plasmid liposome gene
therapy decreases ionizing irradiation-induced lipid per-
oxidation of the esophagus. In Vivo 19: 997–1004, 2005.
SODS AND RADIATION THERAPY 1583
59. Epperly MW, Wegner R, Kanai AJ, Kagan VE, Greenberger
EE, Nie S, and Greenberger JS. Effects of MnSOD-plasmid
liposome gene therapy on antioxidant levels in irradiated
murine oral cavity orthotopic tumors. Radiat Res 167: 289–297,
2007.
60. Ermakov AV, Konkova MS, Kostyuk SV, Egolina NA,
Efremova LV, and Veiko NN. Oxidative stress as a signif-
icant factor for development of an adaptive response in
irradiated and nonirradiated human lymphocytes after in-
ducing the bystander effect by low-dose X-radiation. Mutat
Res 669: 155–161, 2009.
61. Ermakov AV, Konkova MS, Kostyuk SV, Smirnova TD,
Malinovskaya EM, Efremova LV, and Veiko NN. An ex-
tracellular DNA mediated bystander effect produced from
low dose irradiated endothelial cells. Mutat Res 712: 1–10,
2011.
62. Esworthy RS, Ho Y-S, and Chu F-F. The Gpx1 gene encodes
mitochondrial glutathione peroxidase in the mouse liver.
Arch Biochem Biophys 340: 59–63, 1997.
63. Fan M, Ahmed KM, Coleman MC, Spitz DR, and Li JJ.
Nuclear factor-jB and manganese superoxide dismutase
mediate adaptive radioresistance in low-dose irradiated
mouse skin epithelial cells. Cancer Res 67: 3220–3228, 2007.
64. Feng X-P, Yi H, Li M-Y, Li X-H, Yi B, Zhang P-F, Li C, Peng
F, Tang C-E, Li J-L, Chen Z-C, and Xiao Z-Q. Identification
of biomarkers for predicting nasopharyngeal carcinoma
response to radiotherapy by proteomics. Cancer Res 70:
3450–3462, 2010.
65. Fernandez-Palomo C, Schultke E, Smith R, Brauer-Krisch E,
Laissue J, Schroll C, Fazzari J, Seymour C, and Mothersill C.
Bystander effects in tumor-free and tumor-bearing rat
brains following irradiation by synchrotron X-rays. Int J
Radiat Biol 89: 445–453, 2013.
66. Fisher CJ and Goswami PC. Mitochondria-targeted anti-
oxidant enzyme activity regulates radioresistance in human
pancreatic cancer cells. Cancer Biol Ther 7: 1271–1279, 2008.
67. Fishman K, Baure J, Zou Y, Huang T-T, Andres-Mach M,
Rola R, Suarez T, Acharya M, Limoli CL, Lamborn KR, and
Fike JR. Radiation-induced reductions in neurogenesis are
ameliorated in mice deficient in CuZnSOD or MnSOD. Free
Radic Biol Med 47: 1459–1467, 2009.
68. Folz RJ and Crapo JD. Extracellular superoxide dismutase
(SOD3): tissue-specific expression, genomic characteriza-
tion, and computer-assisted sequence analysis of the hu-
man EC SOD gene. Genomics 22: 162–171, 1994.
69. Forman HJ, Fukuto JM, and Torres M. Redox signaling:
thiol chemistry defines which reactive oxygen and nitrogen
species can act as second messengers. Am J Physiol Cell
Physiol 287: C246–C256, 2004.
70. Fridovich I. The biology of oxygen radicals. Science 201:
875–880, 1978.
71. Fridovich I. Superoxide dismutases. An adaptation to a
paramagnetic gas. J Biol Chem 264: 7761–7764, 1989.
72. Gao Z, Sarsour EH, Kalen AL, Li L, Kumar MG, and
Goswami PC. Late ROS accumulation and radiosensitivity
in SOD1-overexpressing human glioma cells. Free Radic Biol
Med 45: 1501–1509, 2008.
73. Gauter-Fleckenstein B, Fleckenstein K, Owzar K, Jiang C,
Batinic-Haberle I, and Vujaskovic Z. Comparison of two Mn
porphyrin-based mimics of superoxide dismutase in pulmo-
nary radioprotection. Free Radic Biol Med 44: 982–989, 2008.
74. Gauter-Fleckenstein B, Fleckenstein K, Owzar K, Jiang C,
Reboucas JS, Batinic-Haberle I, and Vujaskovic Z. Early and
late administration of MnTE-2-PyP5 + in mitigation and
treatment of radiation-induced lung damage. Free Rad Biol
Med 48: 1034–1043, 2010.
75. Gius D and Spitz DR. Redox signaling in cancer biology.
Antioxid Redox Signal 8: 1249–1252, 2006.
76. Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura
D, and Jain RK. Normalization of the vasculature for
treatment of cancer and other diseases. Physiol Rev 91:
1071–1121, 2011.
77. Goodhead DT. The initial physical damage produced by
ionizing radiations. Int J Radiat Biol 56: 623–634, 1989.
78. Goodhead DT. Initial events in the cellular effects of ion-
izing radiations: clustered damage in DNA. Int J Radiat Biol
65: 7–17, 1994.
79. Gorman S, Fox E, O’Donoghue D, Sheahan K, Hyland J,
Mulcahy H, Loeb LA, and O’Sullivan J. Mitochondrial
mutagenesis induced by tumor-specific radiation bystander
effects. J Mol Med 88: 701–708, 2010.
80. Gorman S, Tosetto M, Lyng F, Howe O, Sheahan K,
O’Donoghue D, Hyland J, Mulcahy H, and O’Sullivan J.
Radiation and chemotherapy bystanders effects induce
early genomic instability events: telomere shortening and
bridge formation coupled with mitochondrial dysfunction.
Mutat Res 669: 131–138, 2009.
81. Gough DR and Cotter TG. Hydrogen peroxide: a Jekyll and
Hyde signalling molecule. Cell Death Disease 2: e213, 2011.
82. Gray LH, Conger AD, Ebert M, Hornsey S, and Scott OCA.
The concentration of oxygen dissolved in tissues at the time
or irradiation as a factor in radiotherapy. Br J Radiol 26:
638–648, 1953.
83. Grivennikova VG and Vinogradov AD. Generation of su-
peroxide by the mitochondrial complex I. Biochim Biophys
Acta 1757: 553–561, 2006.
84. Guo G, Yan-Sanders Y, Lyn-Cook BD, Wang T, Tamae D,
Ogi J, Khaletskiy A, Li Z, Weydert C, Longmate JA, Huang
T-T, Spitz DR, Oberley LW, and Li JJ. Manganese superoxide
dismutase-mediated gene expression in radiation-induced
adaptive responses. Mol Cell Biol 23: 2362–2378, 2003.
85. Guo H, Seixas-Silva Jr JA, Epperly MW, Gretton JE, Shin
DM, Bar-Sagi D, Archer H, and Greenberger JS. Prevention
of radiation-induced oral cavity mucositis by plasmid/li-
posome delivery of the human manganese superoxide
dismutase (SOD2) transgene. Radiat Res 159: 361–370, 2003.
86. Guo HL, Wolfe D, Epperly MW, Huang S, Liu K, Glorioso
JC, Greenberger J, and Blumberg D. Gene transfer of human
manganese superoxide dismutase protects small intestinal
villi from radiation injury. J Gastrointest Surg 7: 229–236, 2003.
87. Hall EJ. The bystander effect. Health Phys 85: 31–35, 2003.
88. Hall EJ and Giaccia AJ. Radiobiology for the Radiologist. New
York: Lippincott, Williams, and Wilkins, 2006.
89. Hei TK, Ballas LK, Brenner DJ, and Geard CR. Advances in
radiobiological studies using a microbeam. J Radiat Res 50:
A7–A12, 2009.
90. Hempel N, Carrico PM, and Melendez JA. Manganese su-
peroxide dismutase (Sod2) and redox-control of signaling
events that drive metastasis. Anti Cancer Agents Med Chem
11: 191–201, 2011.
91. Hileman EO, Liu J, Albitar M, Keating MJ, and Huang P.
Intrinsic oxidative stress in cancer cells: a biochemical basis
for therapeutic selectivity. Cancer Chemother Pharmacol 53:
209–219, 2004.
92. Hjalmarsson K, Marklund SL, Engstrom A, and Edlund T.
Isolation and sequence of complimentary DNA encoding
human extracellular superoxide dismutase. Proc Natl Acad
Sci U S A 84: 6340–6344, 1987.
1584 HOLLEY ET AL.
93. Ho JC-m, Zheng S, Comhair SAA, Farver C, and Erzurum SC.
Differential expression of manganese superoxide dismutase
and catalase in lung cancer. Cancer Res 61: 8578–8585, 2001.
94. Holley AK, Dhar SK, and St. Clair DK. Curbing cancer’s
sweet tooth: is there a role for MnSOD in regulation of the
Warburg effect? Mitochondrion 13: 170–188, 2013.
95. Holley AK, Kiningham KK, Spitz DR, Edwards DP, Jenkins
JT, and Moore MR. Progestin stimulation of manganese su-
peroxide dismutase and invasive properties in T47D human
breast cancer cells. J Steroid Biochem Mol Biol 117: 23–30, 2009.
96. Holley AK, Xu Y, St. Clair DK, and St. Clair WH. RelB
regulates manganese superoxide dismutase gene and re-
sistance to ionizing radiation of prostate cancer cells. Ann N
Y Acad Sci 1201: 129–136, 2010.
97. Hoye AT, Davoren JE, Wipf P, Fink MP, and Kagan VE.
Targeting mitochondria. Acc Chem Res 41: 87–97, 2008.
98. Hsieh C-H, Lee C-H, Liang J-A, Yu C-Y, and Shyu W-C.
Cycling hypoxia increases U87 glioma cell radioresistance
via ROS induced higher and long-term HIF-1 signal
transduction activity. Oncol Rep 24: 1629–1636, 2010.
99. Hu H, Luo M-L, Du X-L, Feng Y-B, Zhang Y, Shen X-M, Xu
X, Cai Y, Han Y-L, and Wang M-R. Up-regulated manga-
nese superoxide dismutase expression increases apoptosis
resistance in human esophageal squamous cell carcinomas.
Chin Med J 120: 2092–2098, 2007.
100. Hu Y, Rosen DG, Zhou Y, Feng L, Yang G, Liu J, and Huang
P. Mitochondrial manganese-superoxide dismutase expres-
sion in ovarian cancer: role in cell proliferation and response
to oxidative stress. J Biol Chem 280: 39485–39492, 2005.
101. Hwang TS, Choi HK, and Han HS. Differential expression
of manganese superoxide dismutase, copper/zinc super-
oxide dismutase, and catalase in gastric adenocarcinoma
and normal gastric mucosa. EJSO 33: 474–479, 2007.
102. Iyer R and Lehnert BE. Alpha-particle induced increases in
the radioresistance of normal human bystander effects.
Radiat Res 157: 3–7, 2002.
103. Izutani R, Asano S, Imano M, Kuroda D, Kato M, and
Ohyanagi H. Expression of manganese superoxide dis-
mutase in esophageal and gastric cancers. J Gastroenterol 33:
816–822, 1998.
104. Janssen AML, Bosman CB, van Duijn W, Oostendorp-van
de Ruit MM, Kubben FJGM, Griffioen G, Lamers BBHW,
van Krieken JHJM, van de Velde CJH, and Verspaget HW.
Superoxide dismutases in gastric and esophageal cancer
and the prognostic impact in gastric cancer. Clin Cancer Res
6: 3183–3192, 2000.
105. Jemal A, Bray F, Center MM, Ferlay J, Ward E, and Forman
D. Global cancer statistics. CA Cancer J Clin 61: 69–90, 2011.
106. Jordan BF and Sonveaux P. Targeting tumor perfusion and
oxygenation to improve the outcome of anticancer therapy.
Front Pharmacol 3: 1–15, 2012.
107. Josson S, Sharp S, Sung S-Y, Johnstone PAS, Aneja R, Wang
R, Gururajan M, Turner T, Chung LWK, and Yates C. Tu-
mor-stromal interactions influence radiation sensitivity in
epithelial-versus mesenchymal-like prostate cancer cells.
J Oncol pii: 232831, 2010.
108. Josson S, Xu Y, Fang F, Dhar SK, St. Clair DK, and St. Clair
WH. RelB regulates manganese superoxide dismutase gene
and resistance to ionizing radiation of prostate cancer cells.
Oncogene 25: 1554–1559, 2006.
109. Kalen AL, Sarsour EH, Venkataraman S, and Goswami PC.
Mn-superoxide dismutase overexpression enhances G2 ac-
cumulation and radioresistance in human oral squamous
carcinoma cells. Antioxid Redox Signal 8: 1273–1281, 2006.
110. Kanai AJ, Zeidel ML, Lavelle JP, Greenberger JS, Birder LA,
De Groat WC, Apodaca GL, Meyers SA, Ramage R, and
Epperly MW. Manganese superoxide dismutase gene
therapy protects against irradiation-induced cystitis. Am J
Physiol Renal Physiol 283: F1304–F1312, 2002.
111. Kang SK, Rabbani ZN, Folz RJ, Golson ML, Huang H, Yu
D, Samulski TS, Dewhirst MW, Anscher MS, and Vu-
jaskovic Z. Overexpression of extracellular superoxide
dismutase protects mice from radiation-induced lung in-
jury. Int J Radiat Oncol Biol Phys 57: 1056–1066, 2003.
112. Kashino G, Prise KM, Schettino G, Folkard M, Vojnovic B,
Michael BD, Suzuki K, Kodama S, and Watanabe M. Evi-
dence for induction of DNA double strand breaks in the
bystander response to targeted soft X-rays in CHO cells.
Mutat Res 556: 209–215, 2004.
113. Keele BB, Jr., McCord JM, and Fridovich I. Further char-
acterization of bovine superoxide dismutase and its isola-
tion from bovine heart. J Biol Chem 246: 2875–2880, 1971.
114. Khan MA, Hill RP, and Van Dyk J. Partial volume rat lung
irradiation: an evaluation of early DNA damage. Int J Ra-
diat Oncol Biol Phys 40: 467–476, 1998.
115. Khan MA, Van Dyk J, Yeung IWT, and Hill RP. Partial
volume rat lung irradiation; assessment of early DNA
damage in different lung regions and effect of radical
scavengers. Radiother Oncol 66: 95–102, 2003.
116. Kiningham KK, Daosukho C, and St. Clair DK. IjBa (in-
hibitory jBa) identified as labile repressor of MnSOD
(manganese superoxide dismutase) expression. Biochem J
384: 543–549, 2004.
117. Kiningham KK, Xu Y, Daosukho C, Popova B, and St. Clair
DK. Nuclear factor jB-dependent mechanisms coordinate
the synergistic effect of PMA and cytokines on the induction
of superoxide dismutase 2. Biochem J 353: 147–156, 2001.
118. Kostyuk SV, Ermakov AV, Alekseeva AY, Smirnova TD,
Glebova KV, Efremova LV, Baranova A, and Veiko NN.
Role of extracellular DNA oxidative modification in radi-
ation induced bystander effects in human endotheliocytes.
Mutat Res 729: 52–60, 2012.
119. Koturbash I, Kutanzi K, Hendrickson K, Rodriguez-Juarez
R, Kogosov D, and Kovalchuk O. Radiation-induced by-
stander effects in vivo are sex specific. Mutat Res 642: 28–36,
2008.
120. Koturbash I, Loree J, Kutanzi K, Koganow C, Pogribny I,
and Kovalchuk O. In vivo bystander effect: cranial x-irradi-
ation leads to elevated DNA damage, altered cellular pro-
liferation and apoptosis, and increased p53 levels in shielded
spleen. Int J Radiat Oncol Biol Phys 70: 554–562, 2008.
121. Lee JH, Choi IY, Kil IS, Kim SY, Yang ES, and Park J-W.
Protective role of superoxide dismutases against ionizing
radiation in yeast. Biochim Biophys Acta 1526: 191–198,
2001.
122. Lenaz G. The mitochondrial production of reactive oxygen
species: mechanisms and implications in human pathology.
IUBMB Life 52: 159–164, 2001.
123. Lewis DA, Mayhugh BM, Qin Y, Trott K, and Mendonca
MS. Production of delayed death and neoplastic transfor-
mation in CGL1 cells by radiation-induced bystander ef-
fects. Radiat Res 156: 251–258, 2001.
124. Li F and Sethi G. Targeting transcription factor NF-kappaB
to overcome chemoresistance and radioresistance in cancer
therapy. Biochim Biophys Acta 1805: 167–180, 2010.
125. Li H, Wang Y, Pazhanisamy SK, Shao L, Batinic-Haberle I,
Meng A, and Zhou D. Mn(III) meso-tetrakis-(N-ethylpyridinium-
2-yl) porphyrin mitigates total body irradiation-induced
SODS AND RADIATION THERAPY 1585
long-term bone marrow suppression. Free Radic Biol Med
51: 30–37, 2011.
126. Li S, Yan T, Yang J-Q, Oberley TD, and Oberley LW. The
role of cellular glutathione peroxidase redox regulation in
the suppression of tumor cell growth by manganese su-
peroxide dismutase. Cancer Res 60: 3927–3939, 2000.
127. Lyng FM, Howe OL, and McClean B. Reactive oxygen
species-induced release of signalling factors in irradiated
cells triggers membrane signalling and calcium influx in
bystander cells. Int J Radiat Biol 87: 683–695, 2011.
128. Lyng FM, Seymour CB, and Mothersill C. Production of a
signal by irradiated cells which leads to a response in un-
irradiated cells characteristic of initiation of apoptosis. Br J
Cancer 83: 1223–1230, 2000.
129. Lyng FM, Seymour CB, and Mothersill C. Initiation of ap-
optosis in cells exposed to medium from the progeny of
irradiated cells: a possible mechanism for bystander-in-
duced genomic instability? Radiat Res 157: 365–370, 2002.
130. Maguire P, Mothersill C, Seymour C, and Lyng F. Medium
from irradiated cells induces dose-dependent mi-
tochodnrial changes and BCL2 responses in unirradiated
human keratinocytes. Radiat Res 163: 384–390, 2005.
131. Maiorino M, Scapin M, Ursini F, Biasolo M, Bosello V, and
Flohe L. Distinct promoters determine alternative tran-
scription of gpx-4 into phospholipid-hydroperoxide gluta-
thione peroxidase variants. J Biol Chem 278: 34286–34290,
2003.
132. Malafa M, Margenthaler J, Webb B, Neitzel L, and Chris-
tophersen M. MnSOD expression is increased in metastatic
gastric cancer. J Surg Res 88: 130–134, 2000.
133. Mancuso M, Pasquali E, Leonardi S, Rebessi S, Tanori M,
Giardullo P, Borra F, Pazzaglia S, Naus CC, Di Majo V, and
Saran A. Role of connexin43 and ATP in long-range by-
stander radiation damage and oncogenesis in vivo. Onco-
gene 30: 4601–4608, 2011.
134. Mancuso M, Pasquali E, Leonardi S, Tanori M, Rebessi S,
Di Majo V, Pazzaglia S, Toni MP, Pimpinella M, Covelli V,
and Saran A. Oncogenic bystander radiation effects in
patched heterozygous mouse cerebellum. Proc Natl Acad Sci
U S A 105: 12445–12450, 2008.
135. McCord JM and Fridovich I. Superoxide dismutase: an
enzymic function for erythrocuprein (hemocuprein). J Biol
Chem 244: 6049–6055, 1969.
136. McGee MC, Hamner JB, Williams RF, Rosati SF, Sims TL,
Ng CY, Gaber MW, Calabrese C, Wu J, Nathwani AC,
Duntsch C, Merchant TE, and Davidoff AM. Improved
intratumoral oxygenation through vascular normalization
increases glioma sensitivity to ionizing radiation. Int J Ra-
diat Oncol Biol Phys 76: 1537–1545, 2010.
137. McParland BJ. Nuclear Medicine Radiation Dosimetry. Lon-
don: Springer-Verlag, 2010.
138. Miriyala S, Spasojevic I, Tovmasyan A, Salvemini D, Vu-
jaskovic Z, St. Clair D, and Batinic-Haberle I. Manganese
superoxide dismutase, MnSOD and its mimics. Biochim
Biophys Acta 1822: 794–814, 2012.
139. Moeller BJ, Batinic-Haberle I, Spasojevic I, Rabbani ZN,
Anscher MS, Vujaskovic Z, and Dewhirst MW. A manga-
nese porphyrin superoxide dismutase mimetic enhances
tumor radioresponsiveness. Int J Radiat Oncol Biol Phys 63:
545–552, 2005.
140. Mohr A, Buneker C, Gough RP, and Zwacka RM. MnSOD
protects colorectal cancer cells from TRAIL-induced apo-
ptosis by inhibition of Smac/DIABLO release. Oncogene 27:
763–774, 2008.
141. Mothersill C and Seymour C. Medium from irradiated
human epithelial cells but not human fibroblasts reduces
the clonogenic survival of unirradiated cells. Int J Radiat Biol
71: 421–427, 1997.
142. Mottram JC. A factor of importance in the radio sensitivity
of tumors. Br J Radiol 9: 606–614, 1936.
143. Murphy JEJ, Nugent S, Seymour C, and Mothersill C. Mi-
tochondrial DNA point mutations and a novel deletion
induced by direct low-LET radiation and by medium from
irradiated cells. Mutat Res 585: 127–136, 2005.
144. Murphy MP. How mitochondria produce reactive oxygen
species. Biochem J 417: 1–13, 2009.
145. Nagasawa H and Little JB. Induction of sister chromatid
exchanges by extremely low doses of a-particles. Cancer Res
52: 6394–6396, 1992.
146. Nias AHW. An Introduction to Radiobiology. Chichester,
United Kingdom: John Wiley and Sons Ltd, 1998.
147. Nelson KK, Ranganathan AC, Mansouri J, Rodriguez AM,
Providence KM, Rutter JL, Pumiglia K, Bennett JA, and
Melendez JA. Elevated Sod2 activity augments matrix me-
talloproteinase expression: evidence for the involvement of
endogenous hydrogen peroxide in regulating metastasis.
Clin Cancer Res 9: 424–432, 2003.
148. Niciforovic A, Djordjevic J, Adzic M, Vucic V, Mitrasinovic
PM, and Radojcic MB. Experimental and systems biology
studies of the molecular basis for the radioresistance of
prostate carcinoma cells. Ann Biomed Eng 36: 831–838, 2008.
149. Nozoe T, Honda M, Inutsuka S, Yasuda M, and Korenaga
D. Significance of immunohistochemical expression of
manganese superoxide dismutase as a marker of malignant
potential in colorectal carcinoma. Oncol Rep 10: 39–43, 2003.
150. Nugent S, Mothersill CE, Seymour C, McClean B, Lyng FM,
and Murphy JEJ. Altered mitochondrial function and ge-
nome frequency post exposure to c-radiation and bystander
factors. Int J Radiat Biol 86: 829–841, 2010.
151. Nugent SME, Mothersill CE, Seymour C, McClean B, Lyng
FM, and Murphy JEJ. Increased mitochondrial mass in cells
with functionally compromised mitochondria after expo-
sure to both direct c radiation and bystander factors. Radiat
Res 168: 134–142, 2007.
152. O’Neill P and Wardman P. Radiation chemistry comes
before radiation biology. Int J Radiat Biol 85: 9–25, 2009.
153. Oberley LW and Buettner GR. Role of superoxide dis-
mutase in cancer: a review. Cancer Res 39: 1141–1149, 1979.
154. Oberley TD and Oberley LW. Antioxidant enzyme levels in
cancer. Histol Histopathol 12: 525–535, 1997.
155. Oberley TD, Verwiebe E, Zhong W, Kang SW, and Rhee
SG. Localization of the thioredoxin system in normal rat
kidney. Free Radic Biol Med 30: 412–424, 2001.
156. Ohuchida K, Mizumoto K, Murakami M, Qian L-W, Sato
N, Nagai E, Matsumoto K, Nakamura T, and Tanaka M.
Radiation to stromal fibroblasts increases invasiveness of
pancreatic cancer cells through tumor-stromal interactions.
Cancer Res 64: 3215–3222, 2004.
157. Okado-Matsumoto A and Fridovich I. Subcellular distri-
bution of superoxide dismutases (SOD) in rat liver. Cu, Zn-
SOD in mitochondria. J Biol Chem 276: 38388–38393, 2001.
158. Palazzotti B, Pani G, Colavitti R, de Leo ME, Bedogni B,
Borrello S, and Galeotti T. Increased growth capacity of
cervical-carcinoma cells over-expressing manganous su-
peroxide dismutase. Int J Cancer 82: 145–150, 1999.
159. Pandey BN, Kumar A, Ali M, and Mishra KP. Bystander
effect of conditioned medium from low and high doses of c-
irradiated human leukemic cells on normal lymphocytes
1586 HOLLEY ET AL.
and cancer cells. J Environ Pathol Toxicol Oncol 30: 333–340,
2011.
160. Panfili E, Sandri G, and Ernster L. Distribution of gluta-
thione peroxidases and glutathione reductase in rat brain
mitochondria. FEBS Lett 290: 35–37, 1991.
161. Pani G, Galeotti T, and Chiarugi P. Metastasis: cancer cell’s
escape from oxidative stress. Cancer Metastasis Rev 29: 351–
378, 2010.
162. Persaud R, Zhou H, Baker SE, Hei TK, and Hall EJ. As-
sessment of low linear energy transfer radiation-induced
bystander mutagenesis in a three-dimensional culture
model. Cancer Res 65: 9876–9882, 2005.
163. Persaud R, Zhou H, Hei TK, and Hall EJ. Demonstration of
a radiation-induced bystander effect for low dose low LET
b-particles. Radiat Environ Biophys 46: 395–400, 2007.
164. Petkau A. Radiation protection by superoxide dismutase.
Photochem Photobiol 28: 765–774, 1978.
165. Petkau A, Chelack WS, Pleskach SD, Meeker BE, and Brady
CM. Radioprotection of mice by superoxide dismutase.
Biochem Biophys Res Commun 65: 886–893, 1975.
166. Pljesa-Ercegova M, Mimic-Oka J, Dragicevic D, Savic-Ra-
dojevic A, Opacic M, Pljesa S, Radosavljevic R, and Simic T.
Altered antioxidant capacity in human renal cell carcino-
ma: role of glutathione associated enzymes. Urol Oncol26:
175–181, 2008.
167. Pouget J-P, Frelon S, Ravanat J-L, Testard I, Odin F, and
Cadet J. Formation of modified DNA bases in cells exposed
either to gamma radiation or to high-LET particles. Radiat
Res 157: 589–595, 2002.
168. Powis G and Kirkpatrick DL. Thioredoxin signaling as a target
for cancer therapy. Curr Opin Pharmacol 7: 392–397, 2007.
169. Prise KM, Belyakov OV, Folkard M, and Michael BD. Studies
of bystander effects in human fibroblasts using a charged
particle microbeam. Int J Radiat Biol 74: 793–798, 1998.
170. Prise KM, Schettino G, Vojnovic B, Belyakov O, and Shao
C. Microbeam studies of the bystander response. J Radiat
Res 50: A1–A6, 2009.
171. Przybyszewski WM, Widel M, Szurko A, Lubecka B,
Matulewicz L, Maniakowski Z, Polaniak R, Birkner E, and
Rzeszowska-Wolny J. Multiple bystander effect of irradi-
ated megacolonies of melanoma cells on non-irradiated
neighbors. Cancer Lett 214: 91–102, 2004.
172. Qu Y, Zhang H, Zhao S, Hong J, and Tang C. The effect on
radioresistance of manganese superoxide dismutase in na-
sophryngeal carcinoma. Oncol Rep 23: 1005–1011, 2010.
173. Qu Y, Zhao S, Hong J, and Tang S. Radiosensitive gene
therapy through imRNA expression for silencing manga-
nese superoxide dismutase. J Cancer Res Clin Oncol 136:
953–959, 2010.
174. Rabbani ZN, Anscher MS, Folz RJ, Archer E, Huang H,
Chen L, Golson ML, Samulski TS, Dewhirst MW, and
Vujaskovic Z. Overexpression of extracellular superoxide
dismutase reduces acute radiation induced lung toxicity.
BMC Cancer 5: 59, 2005.
175. Rabbani ZN, Batinic-Haberle I, Anscher MS, Huang J, Day
BJ, Alexander E, Dewhirst MW, and Vujaskovic Z. Long-
term administration of a small molecular weight catalytic
metalloporphyrin antioxidant, AEOL 10150, protects lungs
from radiation-induced injury. Int J Radiat Oncol Biol Phys
67: 573–580, 2007.
176. Rabbani ZN, Salahuddin FK, Yarmolenko P, Batinic-
Haberle I, Thrasher BA, Gauter-Fleckenstein B, Dewhirst
MW, Anscher MS, and Vujaskovic Z. Low molecular
weight catalytic metalloporphyrin antioxidant AEOL 10150
protects lungs from fractionated radiation. Free Radic Res
41: 1273–1282, 2007.
177. Radi R, Turrens JF, Chang LY, Bush KM, Crapo JD, and
Freeman BA. Detection of catalase in rat heart mitochon-
dria. J Biol Chem 266: 22028–22034, 1991.
178. Rajendran S, Harrison SH, Thomas RA, and Tucker JD. The
role of mitochondria in the radiation-induced bystander effect
in human lymphoblastoid cells. Radiat Res 175: 159–171, 2011.
179. Ravindranath SD and Fridovich I. Isolation and character-
ization of a manganese-containing superoxide dismutase
from yeast. J Biol Chem 250: 6107–6112, 1975.
180. Regulus P, Duroux B, Bayle P-A, Favier A, Cadet J, and
Ravanat J-L. Oxidation of the sugar moiety of DNA by
ionizing radiation or bleomycin could induce the formation
of a cluster DNA lesion. Proc Natl Acad Sci U S A 104:
14032–14037, 2007.
181. Rhee SG, Chang T-S, Bae YS, Lee S-R, and Kang SW. Cel-
lular regulation by hydrogen peroxide. J Am Soc Nephrol 14:
S211–S215, 2003.
182. Sachs RK, Chen P-L, Hahnfeldt PJ, and Hlatky LR. DNA
damage caused by ionizing radiation. Math Biosci 112: 271–
303, 1992.
183. Salvi M, Battaglia V, Brunati AM, La Rocca N, Tibaldi E,
Pietrangeli P, Marcocci L, Mondovi B, Rossi CA, and To-
ninello A. Catalase takes part in rat liver mitochondria
oxidative stress defense. J Biol Chem 282: 24407–24415, 2007.
184. Salzman R, Kankova K, Pacal L, Tomandl J, Horakova Z,
and Kostrica R. Increased activity of superoxide dismutase in
advanced stages of head and neck squamous cell carcinoma
with locoregional metastases. Neoplasma 54: 321–325, 2007.
185. Schilling-Toth B, Sandor N, Kis E, Kadhim M, Safrany G,
and Hegyesi H. Analysis of the common deletions in the
mitochondrial DNA is a sensitive biomarker detecting di-
rect and non-targeted cellular effects of low dose ionizing
radiation. Mutat Res 716: 33–39, 2011.
186. Secomb TW, Hsu R, Ong ET, Gross JF, and Dewhirst MW.
Analysis of the effects of oxygen supply and demand on
hypoxic fraction in tumors. Acta Oncol 34: 313–316, 1995.
187. Senftleben U, Cao Y, Xiao G, Greten FR, Krahn G, Bonizzi
G, Chen Y, Hu Y, Fong A, Sun S-C, and Karin M. Activa-
tion by IKKa of a second, evolutionary conserved, NF-jB
signaling pathway. Science 293: 1495–1499, 2001.
188. Seo MS, Kang SW, Kim K, Baines IC, Lee TH, and Rhee SG.
Identification of a new type of mammalian peroxiredoxin
that forms an intramolecular disulfide as a reaction inter-
mediate. J Biol Chem 275: 20346–20354, 2000.
189. Sharma KKK, Swarts SG, and Bernhard WA. Mechanisms of
direct radiation damage to DNA: the effect of base sequence
on base end products. J Phys Chem B 115: 4843–4855, 2011.
190. Shibata E, Nanri H, Ejima K, Araki M, Fukuda J, Yoshimura
K, Toki N, Ikeda M, and Kashmura M. Enhancement of
mitochondrial oxidative stress and up-regulation of antiox-
idant protein peroxiredoxin III/SP-22 in the mitochondria of
human pre-eclamptic placentae. Placenta 24: 698–705, 2003.
191. Singh SK, Wang M, Staudt C, and Iliakis G. Post-irradiation
chemical processing of DNA damage generates double-
strand breaks in cells already engaged in repair. Nucleic
Acids Res 39: 8416–8429, 2011.
192. Soini Y, Vakkala M, Kahlos K, Paakko P, and Kinnla V.
MnSOD expression is less frequent in tumour cells of in-
vasive breast carcinomas than in in situ carcinomas or non-
neoplastic breast epithelial cells. J Pathol 195: 156–162, 2001.
193. Southgate TD, Sheard V, Milsom MD, Ward TH, Mairs RJ,
Boyd M, and Fairbairn LJ. Radioprotective gene therapy
SODS AND RADIATION THERAPY 1587
through retroviral expression of manganese superoxide
dismutase. J Gene Med 8: 557–565, 2006.
194. St. Clair DK, Wan XS, Oberley TD, Muse KE, and St. Clair
WH. Suppression of radiation-induced neoplastic trans-
formation by overexpression of mitochondrial superoxide
dismutase. Mol Carcinog 6: 238–242, 1992.
195. Sun J, Chen Y, Li M, and Ge Z. Role of antioxidant enzymes
on ionizing radiation resistance. Free Radic Biol Med 24: 586–
593, 1998.
196. Sun Y, Colburn NH, and Oberley LW. Depression of cata-
lase gene expression after immortalizationa nd transforma-
tion of mouse liver cells. Carcinogenesis 14: 1505–1510, 1993.
197. Sun Y, Oberley LW, Oberley TD, Elwell JH, and Sierra-
Rivera E. Lowered antioxidant enzymes in spontaneously
transformed embryonic mouse liver cells in culture. Carci-
nogenesis 14: 1457–1463, 1993.
198. Sutherland BM, Bennett PV, Sidorkina O, and Laval J.
Clustered DNA damages induced in isolated DNA and in
human cells by low doses of ionizing radiation. Proc Natl
Acad Sci U S A 97: 103–108, 2000.
199. Takada Y, Hachiya M, Park S-H, Osawa Y, Ozawa T, and
Akashi M. Role of reactive oxygen species in cells over-
expressing manganese superoxide dismutase: mechanism for
induction of radioresistance. Mol Cancer Res 1: 137–146, 2002.
200. Takeshige K and Minakami S. NADH- and NADPH-de-
pendent formation of superoxide anions by bovine heart
submitochondrial particles and NADH-ubiquinone reduc-
tase preparation. Biochem J 180: 129–135, 1979.
201. Tannock IF. Oxygen diffusion and the distribution of cel-
lular radiosensitivity in tumors. Br J Radiol 45: 515–524,
1972.
202. Tartier L, Gilchrist S, Burdak-Rothkamm S, Folkard M, and
Prise KM. Cytoplasmic irradiation induces mitochondrial-
dependent 53BP1 protein relocalization in irradiated and
bystander cells. Cancer Res 67: 5872–5879, 2007.
203. Toh Y, Kuninaka S, Oshiro T, Ikeda Y, Nakashima H, Baba
H, Kohnoe S, Okamura T, Mori M, and Sugimachi K.
Overexpression of manganese superoxide dismutase
mRNA may correlate with aggressiveness in gastric an
colorectal adenocarcinomas. Int J Oncol 17: 107–112, 2000.
204. Tominaga T, Hachiya M, Shibata T, Sakamoto Y, Taki K,
and Akashi M. Exogenously-added copper/zinc superox-
ide dismutase rescues damage of endothelial cells from
lethal irradiation. J Clin Biochem Nutr 50: 78–83, 2012.
205. Trumpower BL. The protonmotive Q cycle. Energy trans-
duction by coupling of proton translocation to electron
transfer by the cytochrome bc1 complex. J Biol Chem 265:
11409–11412, 1990.
206. Tsai KKC, Stuart J, Chuang Y-YE, Little JB, and Yuan Z-M.
Low-dose radiation-induced senescent stromal fibroblasts
render nearby breast cancer cells radioresistant. Radiat Res
172: 306–313, 2009.
207. Tsanou E, Ioachim E, Briasoulis E, Damala K, Charchanti
A, Karavasilis V, Pavlidis N, and Agnantis NJ. Im-
munohistochemical expression of superoxide dismutase
(MnSOD) anti-oxidant enzyme in invasive breast carci-
noma. Histol Histopathol 19: 807–813, 2004.
208. Urano M, Kuroda M, Reynolds R, Oberley TD, and St. Clair
DK. Expression of manganese superoxide dismutase re-
duces tumor control radiation dose: gene-radiotherapy.
Cancer Res 55: 2490–2493, 1995.
209. Valko M, Izakovic M, Mazur M, Rhodes CJ, and Telser J.
Role of oxygen radicals in DNA damage and cancer inci-
dence. Mol Cell Biochem 266: 37–56, 2004.
210. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M,
and Telser J. Free radicals and antioxidants in normal
physiological functions and human disease. Int J Biochem
Cell Biol 39: 44–84, 2007.
211. Van der Meeren A, Monti P, Vandamme M, Squiban C,
Wysocki J, and Griffiths N. Abdominal radiation exposure
elicits inflammatory responses and abscopal effects in the
lungs of mice. Radiat Res 163: 144–152, 2005.
212. Vujaskovic Z, Batinic-Haberle I, Rabbani ZN, Feng Q-F,
Kang SK, Spasojevic I, Samulski TV, Fridovich I, Dewhirst
MW, and Anscher MS. A small molecular weight catalytic
metalloporphyrin antioxidant with superoxide dismutase
(SOD) mimetic properties protects lungs from radiation-
induced injury. Free Radic Biol Med 33: 857–863, 2002.
213. Ward JF. DNA damage produced by ionizing radiation in
mammalian cells: identities, mechanisms of formation,
and reparability. Prog Nucleic Acid Res Mol Biol 35: 95–125,
1988.
214. Wardman P. The importance of radiation chemistry to ra-
diation and free radical biology (The 2008 Silvanus
Thompson Memorial Lecture). Br J Radiol 82: 89–104, 2009.
215. Waris G and Ahsan H. Reactive oxygen species: role in the
development of cancer and various chronic conditions.
J Carcinog 5: 14–21, 2006.
216. Weber TJ, Siegel RW, Markillie LM, Chrisler WB, Lei XC,
and Colburn NH. A paracrine signal mediates the cell
transformation response to low dose gamma radiation in
JB6 cells. Mol Carcinog 43: 31–37, 2005.
217. Weisiger RA and Fridovich I. Mitochondrial superoxide
dismutase. Site of synthesis and intramitochondrial locali-
zation. J Biol Chem 248: 4793–4796, 1973.
218. Weitner T, Kos I, Sheng H, Tovmasyan A, Reboucas JS, Fan
P, Waner DS, Vujaskovic Z, Batinic-Haberle I, and Spaso-
jevic I. Comprehensive pharmacokinetic studies and oral
bioavailability of two Mn porphyrin-based SOD mimics,
MnTE-2-PyP(5 + ) and MnTnHex-2-PyP(5 + ). Free Rad Biol
and Med 58: 73–80, 2013.
219. Widel M, Przybyszewski WM, Cieslar-Pobuda A, Saenko
YV, and Rzeszowska-Wolny J. Bystander normal human
fibroblasts reduce damage response in radiation targeted
cancer cells through intercellular ROS level modulation.
Mutat Res 731: 117–124, 2012.
220. Wispe JR, Clark JC, Burhans MS, Kropp KE, Korfhagen TR,
and Whitsett JA. Synthesis and processing of the precursor
for human mangano-superoxide dismutase. Biochim Bio-
phys Acta 994: 30–36, 1989.
221. Xu Y, Fang F, St. Clair DK, Josson S, Sompol P, Spasojevic I,
and St. Clair WH. Suppression of RelB-mediated manganse
superoxide dismutase expression reveals a primary mech-
anism for radiosensitization effect of 1a-25-dihydrox-
yvitamin D3 in prostate cancer cells. Mol Cancer Therapeut 6:
2048–2056, 2007.
222. Xu Y, Fang F, St. Clair DK, Sompol P, Josson S, and St. Clair
WH. SN52, a novel nuclear factor-jB inhibitor, blocks nu-
clear import of RelB:p52 dimer and sensitizes prostate
cancer cells to ionizing radiation. Mol Cancer Therapeut 7:
2367–2376, 2008.
223. Xu Y, Kiningham KK, Devalaraja MN, Yeh C-C, Majima H,
Kasarskis EJ, and St. Clair DK. An intronic NF-jB element
is essential for induction of the human manganese super-
oxide dismutase gene by tumor necrosis factor-a and in-
terleukin-1b. DNA Cell Biol 18: 709–722, 1999.
224. Yakovlev VA, Rabender CS, Sankala H, Gauter-Fleckenstein
B, Fleckenstein K, Batinic-Haberle I, Jackson I, Vujaskovic Z,
1588 HOLLEY ET AL.
Anscher MS, Mikkelsen RB, and Graves PR. Proteomic
analysis of radiation-induced changes in rat lung: modula-
tion by the superoxide dismutase mimetic MnTE-2-PyP5 + .
Int J Radiat Oncol Biol Phys 78: 547–554, 2010.
225. Yang G, Wu L, Chen S, Zhu L, Huang P, Tong L, Zhao Y,
Zhao G, Wang J, Mei T, Xu A, and Wang Y. Mitochondrial
dysfunction resulting from loss of cytochrome c impairs
radiation-induced bystander effect. Br J Cancer 100: 1912–
1916, 2009.
226. Yang H, Asaad N, and Held KD. Medium-mediated in-
tercellular communication is involved in bystander re-
sponses of x-ray-irradiated normal human fibroblasts.
Oncogene 24: 2096–2103, 2005.
227. Yang L-Y, Chen W-L, Lin J-W, Lee S-F, Lee C-C, Hung TI,
Wei Y-H, and Shih C-M. Differential expression of antiox-
idant enzymes in various hepatocellular carcinoma cell
lines. J Cell Biochem 96: 622–631, 2005.
228. Zelko IN, Mariani TJ, and Felz RJ. Superoxide dismutase
multigene family: a comparison of CuZn-SOD (SOD1),
Mn-SOD (SOD2), and EC-SOD (SOD3) gene structure,
evolution, and expression. Free Radic Biol Med 33: 337–349,
2002.
229. Zhou H, Ivanov VN, Gillespie J, Geard CR, Amundson SA,
Brenner DJ, Yu Z, Lieberman HB, and Hei TK. Mechanism
of radiation-induced bystander effect: role of the cycloox-
ygenase-2 signaling pathway. Proc Natl Acad Sci U S A 102:
14641–14646, 2005.
230. Zhou H, Ivanov VN, Lien Y-C, Davidson M, and Hei TK.
Mitochondrial function and nuclear factor-jB-mediated
signaling in radiation-induced bystander effects. Cancer Res
68: 2233–2240, 2008.
231. Zhou H, Randers-Pehrson G, Waldren CA, Vannais D, Hall
EJ, and Hei TK. Induction of a bystander mutagenic effect
of alpha particles in mammalian cells. Proc Natl Acad Sci U
S A 97: 2099–2104, 2000.
232. Zhou H, Suzuki M, Geard CR, and Hei TK. Effects of ir-
radiated medium with or without cells on bystander cell
responses. Mutat Res 499: 135–141, 2002.
233. Zhou H, Suzuki M, Randers-Pehrson G, Vannais D,
Chen G, Trosko JE, Waldren CA, and Hei TK. Radiation
risk to low fluences of a particles may be greater than
we thought. Proc Natl Acad Sci U S A 98: 14410–14415,
2001.
234. Zwacka RM, Dudus L, Epperly MW, Greenberger JS, and
Engelhardt JF. Redox gene therapy protects human IB-3
lung epithelial cells against ionizing radiation-induced ap-
optosis. Human Gene Ther 9: 1381–1386, 1998.
Address correspondence to:
Dr. William H. St. Clair
Department of Radiation Medicine
University of Kentucky
Chandler Medical Center
800 Rose St. N-10
Lexington, KY 40536
E-mail: stclair@uky.edu
Date of first submission to ARS Central, January 17, 2013; date
of final revised submission, September 16, 2013; date of ac-





CHO¼Chinese hamster ovary cells
COX-2¼ cyclooxygenase-2





ECSOD¼ extracellular superoxide dismutase
ER¼ endoplasmic reticulum
ETC¼ electron transport chain







HUVEC¼human umbilical vein endothelial cells
IFN-b¼ interferon-b
IGFBP-3¼ insulin growth factor binding protein 3
















ROS¼ reactive oxygen species
SCC¼ squamous cell carcinoma
SOD¼ superoxide dismutase
SOD1¼ copper-zinc superoxide dismutase
SOD2¼manganese superoxide dismutase
SOD3¼ extracellular superoxide dismutase
TGF-b¼ transforming growth factor-beta
TNF-a¼ tumor necrosis factor-alpha
TPA¼ 12-O-tetradecanoylphorbol-13-acetate
VEGF¼vascular endothelial growth factor
XO¼ xanthine oxidase
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